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Musculoskeletal (MSK) imaging tests are used for diagnosis and management of arthritis. 
Although the technical and performance properties of conventional radiography (CR), 
ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI) are well 
recognised, few studies have examined the patient experience of undergoing these tests. The 
aim of this study was to understand the patient experience of undergoing MSK imaging tests 
and to identify factors that contribute most to the patient experience. 
  
Methods:  
This study consisted of two stages. Stage one involved detailed semi-structured interviews 
with 33 patients with inflammatory arthritis who had undergone a recent joint CR, US, CT or 
MRI scan about their experience of the test. Interviews were transcribed and thematic analysis 
used to identify key themes. 
Stage two involved the generation of questionnaire items about MSK imaging from these 
interviews. Questionnaires were posted to 514 people with inflammatory arthritis who had 
undergone one of the four imaging modalities over a four month period. Respondents were 
asked to rate different aspects of the imaging tests on Likert scales. Variables associated with 
the overall patient experience of the test were analysed using linear regression models. 
 
Results:  
The interviews provided valuable information about the patient experience of MSK imaging. 
Patient knowledge about tests was informed by information they received from their doctor 
and their previous experience of imaging tests. Most patients were aware of potential harm 
from intravenous contrast or radiation. However, patients perceived imaging as part of 
standard clinical care and believed the benefits of tests outweighed the potential risks. 
Discomfort was described; both emotional discomfort due to claustrophobia and negative 
interactions with staff, and physical discomfort due to positioning. Some felt anxious waiting 
for tests or results. Viewing images resulted in improved understanding of disease and a sense 
of personal involvement in their arthritis treatment.  
There were 108 questionnaire respondents. Analysis of the questionnaire items showed that 
there were no significant differences in item answers for the four different imaging 
modalities. Multivariate linear regression identified five question items that were 
independently correlated with overall experience. Two items correlated positively (‘staff 
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made the experience better’ and ‘part of usual care’) and two correlated negatively 
(‘discomfort during the test’ and ‘waiting for the test’). For those who saw their images 




This study has identified factors before, during and after an MSK imaging test that contribute 
to the overall patient experience. Our findings show that MSK imaging tests are well tolerated 
by patients with arthritis who have a realistic perception of their value and potential risks. We 
recommend that patients having these tests are given sufficient information such as the 
approximate waiting time for their test and results and the potential risks of the test. The 
patient experience of MSK imaging for inflammatory arthritis could be optimised by ensuring 
positive interactions with radiology staff with careful consideration of patient comfort during 
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     Musculoskeletal (MSK) imaging tests are frequently undertaken in the clinical care of 
patients with inflammatory arthritis to diagnose and monitor their arthritis.  Our study aims to 
examine the patient experience of undergoing these tests which include conventional 
radiology (CR), ultrasound (US), computed tomography (CT) and magnetic resonance 
imaging (MRI). The study is made up of two stages. In stage one participants who have had a 
recent imaging test are interviewed about their experience. Stage two uses the information 
from stage one to design a postal questionnaire survey, which is sent to patients who have had 
an imaging test. This study will provide valuable new information about the patient 
experience of MSK imaging and will inform clinical decisions regarding the selection of 
imaging modalities for diagnosing or monitoring arthritis. 
 
     The patient experience has been defined in previous studies as a reflection of events that 
happen independently and collectively across the continuum of care with a focus on 
individualized care and tailoring of services to meet patient needs and engage them as 
partners in their care. It is strongly tied to patients’ expectations and is more than satisfaction 
alone (Wolf et al., 2014). The patient experience encompasses patients’ feelings and 
perceptions, but these terms are not interchangeable. 
 
1.2 Musculoskeletal imaging in patients with arthritis 
 
     This chapter will focus on the MSK imaging tests which are used to assess arthritic joints. 
It will look into the differences between them, the advantages and disadvantages of each and 
why a particular imaging test might be selected for a certain patient. It will explore why the 
patients’ experience of MSK imaging tests is important and summarise patients’ experiences 
of imaging tests from previous literature.  
 
     MSK imaging is widely used in rheumatology clinical practice and research settings. 
Imaging tools assist with both diagnosis and monitoring of arthritis. They are also frequently 
used as outcome measures in rheumatology clinical trials. The most commonly used 
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musculoskeletal imaging techniques include CR, US, CT and MRI. These four modalities 
differ substantially from each other, with variation in many factors including: the time 
required to complete scanning, the requirement for scanning in an enclosed space, exposure to 
noise, exposure to radiation, the requirement for joint manipulation or compression, the need 
for intravenous contrast injection, and the ability to acquire, manipulate and view images in 
real-time (Gellhorn & Carlson, 2013; MacKenzie et al., 1995; Thorp et al., 1990). 
 
     Two key aspects of inflammatory arthritis for which an imaging modality is relevant are 
joint inflammation and structural damage. According to the EULAR (European league against 
rheumatism) recommendations for imaging in rheumatoid arthritis (RA) CR of the hands and 
feet should be used as the initial imaging technique to detect structural damage such as 
erosions or joint space narrowing. If that is normal they recommend further imaging with 
either US or MRI (Colebatch et al., 2013) to detect damage at an earlier time point. In regards 
to detection of joint inflammation they note that US and MRI are superior to clinical 
examination by two fold (Colebatch et al., 2013). Nonetheless CR is still the imaging “gold 
standard” used to monitor structural progression in RA drug trials (Baker et al., 2015). In 
peripheral spondyloarthritis EULAR similarly recommends CR to monitor structural damage 
and US or MRI to aid diagnosis and monitor disease activity (Mandl et al., 2015). 
 
     In addition to joint inflammation and structural damage, gout has urate deposition. CR can 
give information on joint damage but not urate deposition or inflammation. US and MRI are 
best to identify synovial inflammation and/or erosions. Both US and DECT can give 
information on urate deposition (Durcan et al., 2015). 
 
     In the early stages of osteoarthritis (OA) developments such as osteophytes, subchondral 
sclerosis, or subchondral cysts are well visualized with CR. However, Braun and Gold (2012) 
recommend a combination of imaging techniques to provide a comprehensive assessment of 
the OA joint. CR can assess joint space width, which provides an indirect measure of the 
integrity of both hyaline and fibrocartilage and MRI can detect additional features such as 
bone marrow oedema like lesions which are areas of bone necrosis and fibrosis associated 
with progressive cartilage damage (Braun & Gold, 2012). Amin et al (2015)  are in agreement 
reporting that 42% of symptomatic patients show cartilage loss on MRI despite CR being 
normal so if CR is used alone a substantial proportion of knees with cartilage loss will be 




     Each imaging modality has specific advantages and disadvantages and the clinician and 
patient must decide together which modality is most appropriate for that patient. Exploration 
of the patient experience may therefore have direct clinical application, by informing 
decisions regarding selection of imaging methods for diagnosis and monitoring of disease, 
particularly where similar information is obtained from multiple modalities.   
 
1.3 The advantages and disadvantages of musculoskeletal 
imaging tests 
 
1.3.1 Conventional radiography 
 
     CR uses x-rays to visualise bones and other internal structures. CR is used interchangeably 
with x-ray in this thesis. CR is easily accessible and relatively safe so is usually the first 
investigation for a patient presenting with joint symptoms. Various pathological abnormalities 
can be assessed using CR, including peri-articular osteopenia, bone cysts, bone erosions, joint 
space narrowing, subluxation, dislocation, sclerosis and ankylosis (Bijlsma, 2012).  It allows 
differentiation of different types of arthritis such as RA, OA, crystal arthropathies and 
psoriatic arthritis, based on specific pathology associated with these conditions. CR  allows 
easy serial comparison for assessment of disease progression and is often part of the basic 
documentation of disease monitoring (Bohndorf & Schalm, 1996).  
      
     In RA the overall sensitivity, specificity and accuracy of CR at detecting erosions in wrist 
bones were 24%, 99% and 63%, respectively (Døhn et al., 2008). CR has a 87.3% agreement 
when compared to CT for the presence of erosion in gout (Dalbeth et al., 2009). However, 
there is an absence of specific radiographic findings in early disease. Erosions only become 
consistently visualised on CR of the metacarpophalangeal joints when 20-30% of the bone is 
eroded on MRI (Aletaha et al., 2010). As the presence of erosions is related to a poor long-
term functional and radiographic outcome it is desirable to detect them early. In gout studies 
US has been shown to identify more small erosions than CR but both tests give comparable 
results when looking at large erosions (Schueller-Weidekamm et al., 2007).  
 
     One disadvantage of CR is exposure to ionising radiation however, the levels are low 
compared to an average annual background radiation of 2 millisieverts (mSv) and to other 
imaging modalities such as CT. An x-ray of an extremity exposes someone to 0.001 mSv and 
a chest x-ray (anteroposterior and lateral) exposes them to 0.1 mSv (Skinner, 2013). To put 
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this into perspective exposures of aircrew to cosmic radiation are typically around 1.8 mSv 
per year for domestic routes, and around 4 mSv per year for international flight routes 
(Arpansa, 2017). Another disadvantage of CR is that it is unable to assess disease activity 
(Colebatch et al., 2013), as it cannot detect inflammation. 
1.3.2 Ultrasound 
 
     Ultrasound (US) is a safe, quick, easily accessible bedside procedure that visualises tissues 
as acoustic reflections. Its strengths are visualising synovitis of joints, bursae and tendon 
sheaths and bone erosions. Over the last decade US has become more accessible to 
rheumatologists and is now done routinely by many rheumatologists in their clinical practice. 
 
     US is more sensitive in detecting bony erosions in RA when compared with CR (Wiell et 
al., 2007). US is effective at detecting enthesitis in spondyloarthritis, such as Achilles 
tendonitis, which can go unnoticed because of the lack of precision and sensitivity of physical 
examination to detect it. Findings of tendonitis on US include thickening and loss of the 
uniform, linear echo pattern of the involved tendon (Pope et al., 2015). US can detect 
crystalline material as it reflects ultrasound waves more strongly than surrounding tissues and 
can be readily distinguished as a parallel hyperechoic line next to the bony contour (Thiele & 
Schlesinger, 2007). This is known as the double contour sign and has been confirmed by 
identification of intra-articular microscopic monosodium urate (MSU) crystals (Naredo et al., 
2014). 
 
     Many arthritis patients deemed to be in clinical remission still have active joint disease 
without any obvious symptoms or physical signs. A recent study found that 75.4% of arthritis 
patients believed to be in clinical remission had ultrasound-positive synovitis at baseline and 
are at risk of further progression of joint damage due to ongoing inflammation (Okano et al., 
2015). Using ultrasound to diagnose active subclinical synovitis can identify patients who 
may benefit from more intensive treatment, preventing further joint damage and subsequent 
disability (Okano et al., 2015), however escalating treatment in asymptomatic patients is not 
widely supported. 
 
     US can be used to directly visualise needle placement during injection or aspiration. Up to 
70% of intra-articular corticosteroid injections are inaccurately placed, which may contribute 
to an inadequate response. One study comparing US guided injections to clinical examination 
guided injections found superior anatomical needle placement in US guided injections leading 
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to greater improvement in joint function for the patient (Cunnington et al., 2010). Other 
studies have shown improvement in joint symptoms following an intra-articular injection 
irrespective of whether the needle was in the targeted structure or not (Hegedus et al., 2010). 
 
     US is a dynamic study allowing the affected part to be imaged in real time, observing for 
pathologic movement in tendons, bursae, muscles, or joints. Further advantages of US are that 
it is less expensive than MRI or CT and patients can be given immediate feedback and started 
on a treatment plan at the same visit, if required (Lento & Primack, 2008). 
 
     One disadvantage of US is that it is highly operator dependent. A study looking at 
rheumatologists performing MSK US demonstrated moderate to good correlations between 14 
independent observers. However they were classified as expert scanners. They then compared 
US and MRI results (45 joints in total) and found an overall agreement of 82% (Scheel et al., 
2005). US has been found to be less reliable in obese patients (Sauvain et al., 2016). Several 
studies have shown a high level of inter-machine reliability regarding patellar tendon length 
measurement (Gellhorn & Carlson, 2013) and grading of power doppler (D'Agostino et al., 
2008).  
 
1.3.3 Computed tomography 
 
     A CT scan uses computer processed combinations of many x-ray images taken from 
different angles to provide tomographic images of the body. CT provides more detailed 
assessment of the severity of joint disease than CR because of its tomographic nature. It is 
especially useful for visualising bone and cartilage, in fact CT is usually the imaging modality 
of choice for evaluating bone (McKinnis, 2014) and it is the “gold standard” for detecting 
bone erosions in gouty arthritis (Dalbeth et al., 2009). It is often used as the reference method 
against which the performances of MRI and US, at detecting erosions, are compared.  
 
    In addition to information obtained from a conventional CT scan, dual energy computed 
tomography (DECT) gives us information about urate deposition. The use of two different x-
ray energies can differentiate iodine, uric acid and calcium from soft tissues. The dual 
energies provide information about tissue composition beyond that obtainable with single-
energy techniques (Coursey et al., 2010). DECT is highly accurate at detecting uric acid 
deposition, therefore is useful in gout. It is often used in patients with suspected gout who 
have a negative aspirate for MSU crystals (Bongartz et al., 2015). DECT use is not 




     The main disadvantage of CT is radiation exposure; the radiation exposure of DECT has 
been calculated at 0.05–0.2 mSv per examined region (Durcan et al., 2015). It varies 
depending on the manufacturer and the specific parameters employed; such as tube current, 
pitch, and energy. If low tube currents are used, radiation doses are similar to those used to 
acquire single-energy images (Coursey et al., 2010). Henzler (2012)  supports this view 
commenting that there is strong evidence that DECT is not associated with increased radiation 
dose levels when compared to CT (Henzler et al., 2012). A CT chest involves 8 mSv of 
radiation, which is equivalent to 400 chest x-rays. The additional lifetime cancer risk after 
having a CT chest is 1 in 1200 compared to a chest x-ray which is 1 in 100,000 (Skinner, 
2013). There is a 5% excess risk of death from cancer with a 1000 mSv radiation dose (Lin, 
2010). 
 
     In general the use of CT in evaluating patients with early inflammatory arthritis is limited, 
as more sensitive tools not requiring radiation are available such as US and MRI (Bijlsma, 
2012). Another disadvantage is the inability to visualise soft tissue structures, other than bone 
and cartilage, with discernible clarity and so is not able to clearly demonstrate changes such 
as infection or inflammation (Bijlsma, 2012).  
 
1.3.4 Magnetic resonance imaging 
 
     MRI uses a combination of a magnet, radiofrequencies and a computer to visualise bone 
and soft tissues in three dimensions using a multiplanar technique and is uniquely suited to 
imaging joints. MRI detects structural damage in the form of bony erosions on average two 
years before they appear on plain radiographs, enabling earlier escalation of treatment 
(Aletaha et al., 2010). It is also more sensitive than CR in demonstrating progressive erosive 
disease. 
 
     MRI has a clear advantage over CR and CT, in its ability to image soft tissues and fluid 
within the joint. Imaging studies comparing CR, US and MRI demonstrate that MRI and US 
are more sensitive at finding inflammatory or destructive changes compared to CR or clinical 
examination  (Wiell et al., 2007). As per US, MRI can detect persistent inflammation of joints 
in people who are thought to be in clinical remission (Colebatch et al., 2013). MRI is unique 
in evaluating bone oedema which appears to be an independent predictor of erosion 




     Unlike CR and CT, there is no exposure to ionised radiation, however intravenous 
gadolinium is often used as a contrast dye to differentiate synovial membrane enhancement 
from the surrounding tissues. Several studies of gadolinium-based contrast agents reported 
finding “deposits in post-mortem brain tissue samples or disrupted signal intensity ratios in 
certain brain areas” of patients who had undergone multiple imaging scans with the agent; the 
significance of this finding is not yet understood (Samson, 2015). There is also a risk of 
nephrotoxicity and allergic reaction to gadolinium (Rogosnitzky & Branch, 2016).  
 
     Another disadvantage of MRI is that many patients have feelings of anxiety, lack of 
control or claustrophobia during the scan, due to the enclosed space, high temperature and 
loud noise (Carlsson & Carlsson, 2013; MacKenzie et al., 1995; Quirk et al., 1989; Törnqviste 
et al., 2006). 
1.4 Why the patient experience is important 
 
     Many factors influence the choice of imaging tests used to evaluate arthritic joints. In 
addition to accuracy and cost, patient preference and tolerance are important considerations, 
when requesting an imaging test (Makanjee et al., 2015). A negative patient experience can be 
caused by a mismatch between their expectation of a procedure and the actual experience of 
the procedure (Nightingale et al., 2012). Failure to meet patient expectations may impact on 
visit satisfaction and patients’ health-related anxiety. As MSK imaging tests are done 
frequently in patients with arthritis it is important to ensure that the patient experience of 
these tests is satisfactory. Although the technical and performance properties of CR, US, CT 
and MRI are well recognised, very few studies have examined the patient experience of 
undergoing imaging tests. The majority that have been done focused on MRI (Carlsson & 
Carlsson, 2013; MacKenzie et al., 1995; Munn & Jordan, 2011; Törnqviste et al., 2006) and 
none were specifically in patients with arthritis.   
 
     The Outcomes in Rheumatology Clinical Trials (OMERACT) group is an international 
initiative that plays a critical role in development, validation and standardisation of clinical 
and radiographic outcome measures for clinical trials in arthritis. OMERACT has a central 
focus on patient participation at each stage of the OMERACT process (de Wit et al., 2014). In 
order for an outcome measure to be endorsed by OMERACT, the measure is assessed 
according to the OMERACT filter which includes three components; truth, discrimination and 
feasibility. Feasibility refers to the practicalities of a tool and patient burden is a core 
consideration in the assessment of feasibility (Wells et al., 2014). In the context of outcome 
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research, patient involvement is essential to ensure that measurement sets are relevant, 
consistent and patient-orientated (de Wit et al., 2013). The lack of data regarding patient 
experience is a major barrier to assessing the feasibility of various imaging outcome measures 
for studies in gout (Grainger et al., 2015). This may also be true for other forms of 
inflammatory arthritis. 
     
     Several studies have commented on the importance of patient participation in clinical 
decision making (Bairstow et al., 2010; Makanjee et al., 2015). Referral for an imaging test 
initiates a complex medical encounter that involves the patient interacting with multiple 
health care providers and technologies (Makanjee et al., 2015). Negative experiences during 
scanning can lead to aborted scans which have financial implications as valuable staff and 
equipment time is lost (Dewey et al., 2007). Makanjee et al. (2015) recommends a patient 
centred approach when conducting a diagnostic imaging test which involves engaging with 
and listening to the patient as an active participant and providing quality professional services. 
 
1.5 Literature review of patients’ experiences of imaging tests 
 
     An electronic narrative literature review was performed searching Pubmed and Science 
Direct using a combination of the following search terms: ‘computed tomography’, 
‘diagnostic’, ‘experience’, ‘imaging’, ‘magnetic resonance’, ‘patient’, ‘perception’, 
‘radiography’ and ‘ultrasound’. The search was limited to papers in English from 1960 
through to 1st of April 2016. The search was not limited to patients with arthritis. There were 
no specific inclusion or exclusion criteria. Bibliographies were also reviewed for relevant 
papers. In total there were fourteen relevant papers; of these ten included MRI and seven were 
exclusively about MRI. There were three each on CR and US and four on CT.  
 
1.5.1 Patients’ experiences during imaging 
 
     There is a lack of data on patients’ experiences during CR and US. Murphy (2001) noted 
several patients were claustrophobic during CT, something that has not been significant in 
previous research (Murphy, 2001). Thorp (1990) explored the patient experience of CT and 
MRI. Patients rated specific features of the procedures as unpleasant; the highest rated were 
side effects of the dye, lying still during the procedure and the confined space. The only 
significant difference between CT and MRI patients was the confined space of the scanner 
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which was rated as unpleasant by a significantly higher proportion of MRI patients (Thorp et 
al., 1990).  
 
     Despite MRI being a non-invasive and painless test, patients often experience anxiety-
related reactions. During an MRI scan 5 to 10% of patients experience severe distress, while 
up to 30% experience considerable apprehension (Melendez & McCrank, 1993). Anxiety 
reactions range from complaints about the duration of the test, the noise inside the bore and 
the high temperature to psychological distress, panic and claustrophobia (MacKenzie et al., 
1995; Melendez & McCrank, 1993). The more serious reactions may result in images of 
reduced diagnostic value secondary to movement artefact or aborted studies, which may be 
costly to the patient and staff. Modern MRI machines which are more patient friendly have 
lower claustrophobia rates (Dewey et al., 2007), however they have not eliminated it. 
 
     Patients also report a wide range of other feelings during MRI, such as feeling as if they 
are in another world or a feeling of loss of control (Törnqviste et al., 2006). Patients are 
frequently surprised at the limited space within the magnetic coil, and many describe the 
experience as comparable to being in a “coffin or a tomb” (Murphy, 2001).   
 
     MacKenzie (1995) conducted one of the largest studies of patients’ experience of MRI. 
More than 300 people filled out a pre and post MRI questionnaire. They found that pre-
imaging anxiety was associated with a previous ‘unpleasant’ imaging experience. Fifteen 
common factors were identified as being ‘unpleasant’ for patients during an MRI scan; the 
four most frequent of these were symptoms of claustrophobia, pain, the scan itself and the 
noise in the scanner (MacKenzie et al., 1995). Interestingly, anxiety was not found to be 
associated with the patient’s understanding of the test, the duration of the test or their previous 
imaging experience (MacKenzie et al., 1995). Pre-imaging anxiety scores differed depending 
on the body region being examined by MRI, for instance knee scores were significantly lower 
than those for spine or head  (MacKenzie et al., 1995) suggesting that feelings of anxiety are 
more intense if the upper body is scanned. Munn (2011) performed a systematic review of 
qualitative studies looking at the patient experience of high technology imaging and found 
that different coping strategies were used in the studies, including visualisation, where the 
participants actively imagined themselves somewhere else, such as on a beach (Munn & 
Jordan, 2011).  




     Carlin (2014) explored patients’ views on seeing their own CR, CT or MRI images. He 
found that patients who were shown their images had enhanced understanding of their 
medical problem. For example a patient commented that pain seemed easier to manage once 
they had seen the source. He also found that it changed the physician-patient interaction as the 
patient felt more involved in the consultation (Carlin et al., 2014). 
 
     In a similar note, Sahbudin (2016) reported reduced anxiety and improved understanding 
in patients undergoing ultrasound guided steroid injection. Much of this appeared to be 
associated with patients seeing the images for themselves (Sahbudin et al., 2016). 
 
1.5.3 Important patient issues 
 
     Studies report that the interaction with radiographers is very important to patients whether 
they feel threatened by the imaging test or not (Carlsson & Carlsson, 2013). In MacKenzie’s 
study (1995) patients identified specific staff actions which had helped them through the 
procedure. The most  important staff behaviours to patients were a friendly manner, good 
communication throughout the scan, providing reassurance to the patient and prior 
explanation of the procedure (MacKenzie et al., 1995).  
     
     Patients perceive time to go more slowly during imaging tests, for instance in Carlsson’s 
study (2013) MRI scanning time was experienced as being very long, even though the longest 
scan was only 30 minutes (Carlsson & Carlsson, 2013). Quirk’s (1989) study also reported an 
impairment of the patients sense of time during MRI scanning; “When you’re in there it feels 
like an eternity” (Quirk et al., 1989). 
 
     In a study comparing patient satisfaction during shoulder US and MRI, US was preferred 
ten times more than MRI. The authors attributed this to the shorter duration of the test and the 
fact that US is interactive, allowing conversation between the patient and examiner and 
opportunity for explanation  (Middleton et al., 2004).  
 
1.5.4 Knowledge about the test 
 
     Studies have shown that patients lack awareness of risks and benefits of different imaging 
tests. A recent study involved patients presenting for cardiac imaging tests to fill out a survey 
on radiation exposure. They found that 43% wrongly believed that MRI involves radiation, 
whereas 84% knew that plain x-ray was associated with radiation. Patients having a CT were 
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more likely to know that a CT utilised radiation than those having other tests (Bannon, 2015). 
This lack of knowledge is surprising as patients are consented for MRIs and CTs and 
therefore should be aware of the risks involved. Seventy nine percent believed the benefits of 
having the test outweighed the radiation risks (Bannon, 2015).  
 
     Another study surveyed emergency department patients on their knowledge of radiation 
exposure from medical imaging, and subsequent radiation-induced malignancies (Repplinger 
et al., 2016). They too found that participants had a limited understanding of the risks of CT 
and MRI. Only 14% correctly identified that CT has 100 times the amount of radiation of CR 
and only a quarter knew of the increased lifetime risk of cancer after 3-5 abdominal CTs. 
Approximately 78% believed that an MRI scan involved radiation and more than half thought 
MRI was associated with an increased cancer risk. The authors identified a significant 
relationship between correctly answered questions and having a college degree or experience 
as a health care professional (Repplinger et al., 2016). 
 
     Makanjee (2015) explored diagnostic imaging from the perspective of the healthcare 
provider and patient. They found a lack of evidence that the risks or benefits of tests or what 
to expect of the test were discussed with patients prior to the tests. This absence of 
information often resulted in the patient being more uncertain about the test. In the majority of 
cases patients were sent for x-rays without seeking their consent. Also they found that patients 
were kept in suspense about who would give them their results and when (Makanjee et al., 
2015).  
 
     Nearly half of the patients in Quirk’s (1989) study reported that they received no 
information on the MRI procedure. In retrospect patients reported they should have been 
given more information on the spatial construction of the MRI, the noise, duration and 
temperature. Sixty nine percent of patients thought they should have been forewarned about 
the extreme constrictiveness of the scan (Quirk et al., 1989). Quirk’s paper recommends that 
as well as being informed about how the MRI scan works and the risks involved, patients 
should also be made aware of the anxiety-producing features of the experience. In Murphy’s 
study (2001) patients most common recommendation was to have the procedure explained 
beforehand and to be shown around the equipment (Murphy, 2001). 
 
     In contrast to this, MacKenzie (1995) discovered that 76% of patients who were having an 
MRI considered that they knew what an MRI involved, compared to 14% who did not and 
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10% who did not respond. The majority (83%) appeared to understand the reason they were 
having the MRI scan done (MacKenzie et al., 1995).  
 
     In summary, previous studies have shown that patients have different experiences of MSK 
imaging tests. Claustrophobia and anxiety are experienced predominantly during MRI scans. 
Patients value good interactions with radiology staff, being provided adequate information 
about the test and viewing their own images. 
 
1.6 Aim of the study 
 
     As evidenced above, there is scant literature on how patients  feel about CR and US. There 
is slightly more data on CT and MRI. However, overall there is very limited data on the 
patient experience of these routine tests which are done frequently for patients with arthritis to 
aid both diagnosis and management. The aim of this study is to examine the patient 
experience of MSK imaging tests for investigation of inflammatory arthritis and to understand 
what factors contribute to the patient experience. Our overarching hypothesis is that patients 
with inflammatory arthritis have specific preferences for MSK imaging tests. Stage two of the 
study will quantify which factors contribute most to the patient experience and discover 
whether different modalities are associated with a different experience. The study results will 
provide valuable information about the patient experience of MSK imaging and will help 
inform clinical decision making about appropriate MSK imaging modalities for patients with 
inflammatory arthritis.  
 
1.7 Outline of Chapters 
 
     Chapter one provides the background to this thesis and outlines the justification for the 
research question. Chapter two will detail the methodology of stage one; this involves semi-
structured interviews with patients post imaging test. Chapter three will report the results of 
stage one detailing the patients’ experiences and feelings in regards to CR, US, CT and MRI. 
Chapter four will describe the methodology of stage two; including the formation of the 
questionnaire and cognitive testing. Stage two involves a postal questionnaire regarding 
patients’ experience of MSK imaging tests. Chapter five will report the results of the postal 
questionnaire survey. Chapter six will discuss and interpret the significance of our findings, 









     The aim of this study is to examine the experience of musculoskeletal imaging for people 
with inflammatory arthritis. It utilised a mixed method approach involving two stages. Stage 
one, the qualitative component, involved semi-structured interviews of patients with arthritis 
who had recently had an imaging test to identify key themes that described their experience. 
These themes were used to develop a questionnaire for stage two, the quantitative component, 
to understand what factors contribute to the patient experience of MSK imaging tests for 
investigation of inflammatory arthritis.  
 
     This chapter will describe the methodology of stage one. It will detail inclusion criteria and 
definitions specific to the study. It will explain the interview structure and process. 
Subsequently it will describe how the interview data was analysed using thematic analysis.  
      
 
2.2 Study Design 
 
     Qualitative research explores the meanings that people attach to their social experiences 
and how they make sense of their world. Meanings and interpretation are complex phenomena 
that cannot be dealt with statistically (Pope & Mays, 2007). Qualitative research involves the 
collection, analysis and interpretation of data which relates to the social world and the 
concepts and behaviours of people within it (Anderson, 2010). As there is little previous 
research on patients’ experience of musculoskeletal imaging, this study was devised with an 
initial qualitative component to explore patients’ beliefs, values and behaviours in greater 
detail, enabling us to identify relevant questions for the questionnaire in stage two. This study 
design, with qualitative research informing generation of a questionnaire has been 
successfully used in previous inflammatory arthritis studies (Aati et al., 2014; Aati et al., 
2015). The main strength of a qualitative approach is that the inquiry is broad allowing 
participants to raise issues that matter most to them. The strength of quantitative studies lies in 
their rapid administration and evaluation time and legitimate, reliable data. Questionnaires 
produce a large amount of data in a short time for a low cost. The disadvantages of 
questionnaires include difficulty securing a high response rate and that the data produced 
often lacks depth on the topic of interest (Kelley et al., 2003). The main disadvantage of 
14 
 
qualitative analysis is that their findings cannot be extended to wider populations with the 
same degree of certainty that quantitative analyses can because the findings are not tested to 
discover whether they are statistically significant or due to chance (Ochieng, 2009). Mixed 
method studies are increasingly recognised as valuable as they combine the strengths of each 
methodology and minimize the weaknesses (Creswell & Plano Clark, 2007). 
 
 
     Inclusion criteria for participants were: being over 18 years of age, able to speak English 
and have had a recent (within the previous six weeks) peripheral joint imaging test for 
diagnosis or management of inflammatory arthritis. Participants in stage one had to be 
capable of providing written informed consent. There was no consent form for stage two, as 
the act of returning the questionnaire indicated consent.  
 
     Imaging tests for inclusion were conventional radiography (CR), ultrasound (US), 
computed tomography (CT) and magnetic resonance imaging (MRI). We did not include 
nuclear medicine tests such as positron emission tomography or dual energy x-ray 
absorptiometry scans in this study as they are not used routinely to diagnose or monitor 
arthritis. 
 
     For this study inflammatory arthritis included confirmed or suspected rheumatoid arthritis, 
psoriatic arthritis, gout, and undifferentiated inflammatory arthritis. Peripheral joints were 
defined as any joints distal to the shoulder (elbow, wrist, hand) in the upper limb and any 
joints distal to the hip (knee, ankle, foot) in the lower limb. A six week time period was 
chosen to ensure recall of the details of the imaging procedure. Many of the participants had 
more than one imaging procedure during this time, and in that situation, all relevant imaging 
procedures were included.  
 
     Participants for both stages were recruited from the rheumatology and radiology outpatient 
departments at Auckland District Health Board (DHB). Stage two participants were also 
recruited from Waitemata DHB. The study was approved by the New Zealand Health and 
Disability Ethics Committee (Approval number 15/CEN/188) and participants in stage one 
provided written informed consent according to ethics committee standard operating 
procedures.   
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2.3 Data collection for stage one 
 
     Participants who fulfilled the inclusion criteria were sent an invitation letter from their 
rheumatology service, asking them to get in contact with the investigator if they wished to be 
involved. To ensure that the breadth of patient experience was captured, purposive sampling 
was used to recruit a diverse range of participants of different ethnicity, sex, age and 
diagnosis. Targeted recruitment methods were used to ensure the inclusion of Māori 
participants.   
 
     Detailed semi-structured interviews were then conducted by a single interviewer (SB). 
This type of interview consists of open-ended questions that aim to explore the experience of 
the musculoskeletal imaging test  but also allow the interviewer to diverge in order to pursue 
an idea or response in more detail (Britten, 1995). The flexibility of this approach, particularly 
compared to structured interviews, also allows for the discovery or elaboration of information 
that is important to participants but may not have previously been thought of as pertinent by 
the research team (Gill et al., 2008).  
 
     An interview schedule was developed following a review of relevant literature regarding 
the patient experience of imaging tests. Additional socio-demographic and clinical 
information such as age, ethnicity and type of arthritis was collected using an interview-
administered semi-structured questionnaire. Participants were initially asked a warm up 
question about their arthritis and the impact that it has on their lives. This was done to 
encourage the participants to ‘open up’ and discuss their experience of the phenomenon in 
detail (Ryan et al., 2007). The remaining questions were divided into four sections; before the 
test, during the test, after the test and overall reflections of the test. The first section focused 
on why they were having the test and the information they were given prior to it. Section two 
covered the procedure in detail and how they felt during it. The next section was about 
receiving the test results; how they felt about the results and the way the results were 
explained to them, or if they had not received their results yet, how they felt about the wait.  
The last section covered their overall experience of the test; any likes or dislikes, any 
concerns about their safety. The interviews were highly interactive, the interviewer aimed to 
be responsive to the language and concepts used by the interviewee and in addition to the 
established questions, used prompts and probes to clarify concepts and elicit detail. The 




     All interviews took place at a location separate from the imaging unit. Travel expenses and 
a $20 koha were provided to participants. Qualitative samples are often small (Fossey et al., 
2002) but this is not a problem as the researcher is not attempting to generalise the findings. 
Data gathered from subsequent participants builds on the information from previous subjects 
and the accumulated data can offer a significant depth of information (Ryan et al., 2007). 
Ethical approval was given for 40 interviews however, if ‘data saturation’ was achieved prior 
to that point the interviews would be terminated early. This was defined as there being 
sufficient data to gain an adequate understanding of the dimensions of the emerging concepts 
and themes (Watling and Lingard (2012).   
 
     Each interview was recorded, with full consent. As the participants were known to the 
researcher doing the interview, total anonymity was not possible. They were assured that their 
identities would not be revealed in any publication and the raw data would not be released to 
any third party and we strived to maintain autonomy. Once the interviews were completed 
they were transcribed verbatim by a professional transcriptionist. Before being analysed 
transcripts were checked and any identifying personal information was removed. 
 
2.4 Data analysis of stage one 
 
     There are two fundamental approaches to analysing qualitative data: deductive and 
inductive approaches. Our study used an inductive approach which is comphrensive and time 
consuming and most suitable when little or nothing is known about the study phenomenon  
(Burnard et al., 2008), as in this case. It involves analysing data with little or no 
predetermined theory, structure or framework and derives the structure of analysis from the 
data itself (Burnard et al., 2008).  
 
     Transcripts were analysed using thematic analysis which  is a widely used method for 
identifying, analysing and reporting patterns (themes) within data (Braun & Clarke, 2006).  
As applied in this study, thematic analysis is a systematic approach to understanding and 
organizing the text obtained from the interviews, into a coherent description of the 
participants’ experiences and opinions. This includes a six-stage process as described by 
Braun and Clarke (2006); familiarisation with the data, generating initial codes, searching for 
themes, reviewing themes, defining and naming themes and producing the report (Braun & 
Clarke, 2006). The NVivo software tool (v8, QSR International) was used to facilitate 




     The first step of analysis involved reading and re-reading the interview data to become 
immersed and intimately familiar with its content. Then initial codes (labels) can be generated 
that identify important features of the data that might be relevant to answering the research 
question. This was done for the entire dataset. As coding proceeds, the analytic process 
enacted is one of ‘constant comparison’, which involves reading and re-reading data to search 
for and identify emerging themes in the constant search to understand the meaning of the data 
(Burnard et al., 2008). Constant comparison enables researchers to treat the data as a whole 
rather than fragmenting it, as one piece of data is compared with previous data and not 




     Figure 2.1. NVivo screen shot 1 
This is a screen shot from the  NVivo program demonstrating the coding process. It shows a 
list of themes and subthemes on the left hand side of the screen and an interview transcript on 







Figure 2.2. NVivo screen shot 2 
     This screen shot of the NVivo program shows a highlighted quote from patient 20. When 
this patient was asked how they found seeing their ultrasound image they commented “then I 
can actually visualise, you know, oh right.  The joints are swollen, that’s why it’s, you know, 
tender and painful”.  This data was coded under the theme ‘seeing is believing’ and the 
subtheme ‘explanation for the pain’. 
 
     The next step was searching for themes. This involved examining all codes and collated 
data to identify significant broader patterns of meaning (potential themes). It then involved 
collating data relevant to each theme and reviewing the viability of each theme. The constant 
comparative process defines the breadth and characteristics of each theme, and facilitates the 
emergence of new themes when data are encountered that illustrate new concepts (Watling & 
Lingard, 2012).  
 
     The following step was reviewing the themes which involved checking the candidate 
themes against the dataset, to determine whether they told a convincing story of the data and 
answered the research question (what is the patient experience of MSK imaging tests?). Three 
members of the research team, including the interviewer, reviewed the interview data and 
initial themes to ensure there was agreement on coding and to limit researchers’ bias.  Any 
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differences in opinion were discussed and resolved by consensus. The themes were refined 
with some being split, combined and discarded. For example, one of the subthemes under 
‘seeing is believing’ was ‘immediate feedback’. This subtheme described patient thoughts on 
the immediate feedback that they get when having an ultrasound performed in clinic. This 
subtheme was moved from the ‘seeing is believing’ theme to the theme ‘experience of waiting 
times’ which describes participant feelings on waiting for a test or results, as it fits this 
category better.  
 
     The last step involved defining the themes, working out the scope and focus of each theme, 
determining the ‘story’ of each and deciding on an informative name for each. The research 
team worked together on this process until the final themes and subthemes were identified. 
 
2.5 Enhancing Rigour 
 
     Rigour is the means of demonstrating  the plausibility, credibility and integrity of the 
qualitative research process (Ryan et al., 2007). The purpose of this study was to explore the 
patients’ experience of MSK imaging. As such the ability to capture and portray the 
participant perspective of MSK imaging was central to promoting authenticity and credibility;  
both important criteria for enhancing rigour (Milne & Oberle, 2005). This required that 
participants had the freedom to speak and that their voices were heard. Recording and 
transcribing the interviews ensured accuracy of the data as well as scientific and ethical 
integrity.  
 
     It has been argued that qualitative researchers should have their analyses verified by a third 
party to provide additional insights into theme and theory development and reduce lone 
researcher bias. There are two key ways of doing this; respondent validation  - returning to the 
study participants and asking them to validate analyses, or peer debrief  - whereby another 
qualitative researcher analyses the data independently (Mays & Pope, 1995). For this study a 
sub-set of transcripts was double coded to ensure consistency of coding decisions across the 
research team and any differences in opinion were discussed and resolved by consensus. This 
process ensured credibility; the issue of whether there is consistency between the participants’ 
views and the researchers’ representation of them (Ryan et al., 2007). The combination of 
qualitative and quantitative methods, as in this study, is referred to as triangulation. 
Triangulation can substantiate the validity of a study, ensuring that the research data is honest 




     To ensure that the analysis process is systematic and rigorous all collected data must be 
thoroughly analysed (Burnard et al., 2008). This includes the search for relevant ‘deviant or 
contrary cases’, which are different to the main findings or unique to one or several 
responders. These “negative cases’’ are particularly important within the constant 
comparative process (Watling & Lingard, 2012). The NVivo software allowed for systematic 




Reflexivity is an important issue in qualitative studies. It refers to recognition of the influence 
a researcher brings to the research process (Kuper et al., 2008) . The interviewer in this study 
comes from a medical background specialising in rheumatology and general medicine. 
Therefore she is biased towards believing that MSK tests are helpful and part of standard 
clinical care for patients with arthritis. None of the participants who were interviewed were 
patients of the interviewer. However they were aware that the interviewer was a doctor, which 
may have skewed their answers towards the positive so as not to be seen as complaining about 
the medical system. The potential overuse of medical jargon during the interviews was 
dampened by the use of a prepared structured interview schedule. This also ensured all 
participants were asked identical questions.  
2.7 Summary 
 
     This chapter outlines the methodology of this study. It clearly states why a mixed methods 
model was chosen. Inclusion criteria and participant recruitment are explained and justified. 
The method for gaining informed consent from participants and preserving subject anonymity 
is described. The semi-structured interview process is described. The decision to stop data 
collection prematurely is explained and justified. Data analysis, verification and methods for 
identifying themes from the data are discussed. The formation of the questionnaire and 




Chapter Three: Results of stage one; 
analysis of the interview data 
 
     This chapter will report the results of stage one, the qualitative component of the study. 
The demographics and disease characteristics of the 33 participants who were interviewed 
will be presented. Subsequently the themes and subthemes which were identified from the 
interviews using thematic analysis will be explored. 
 
3.1 Participant demographics 
 
     Interviews were conducted with 33 participants between 19th January and 19th May 2016. 
There were six participants who had CR alone, ten who had US, ten who had CT and seven 
who had MRI. In total there were 18 participants who had CR, as this test was often done in 
addition to other imaging modalities.  
 
Table 3.1. Participant demographic and disease characteristics.  
Characteristic  N (%) 
Sex Female  17 (52%) 
Ethnicity NZ/European 23 (70%) 
 Māori 4   (12%) 
 Pacific people 2   (6%) 
 Asian 2   (6%) 
 Other 2   (6%) 
Age median (range), years 58 (25 - 83) 
Diagnosis Rheumatoid arthritis 15 (46%) 
 Gout 11 (33%) 
 Inflammatory arthritis (NOS) 6   (18%) 
 Psoriatic arthritis 1   (3%) 
Disease duration median (range), years 9   (0.25 – 45) 
 
     Demographic and clinical characteristics of the interviewees are summarised in Table 3.1. 
Most participants were New Zealand Europeans. Other ethnicities identified were Māori, 
Pacific people, Asian and Other. The ‘other’ patients identified as Indian and Latin American. 
The median age was 58 years (range from 25 to 83 years). Sex distribution was well balanced 
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with 17 females and 16 males. Almost half of the participants had rheumatoid arthritis. The 
remainder had gout, undifferentiated inflammatory arthritis and psoriatic arthritis. Median 
duration of disease was 9 years (range from 0.25 to 45 years).  
 
3.2 Emergent themes 
 
     The analysis of the transcribed interviews identified six key themes (Table 3.2); knowledge 
about the test, awareness of potential harm, the role of imaging in clinical care, discomfort, 
experience of waiting and ‘seeing is believing’. Each theme was supported by data emerging 
from a number of patients. Representative patient quotes are in italics. The identity of the 
speakers is established following the quotes with F for female or M for male, followed by 
their age and imaging modality.  
Table 3.2. Themes and Subthemes  
 
Themes Subthemes 
Knowledge about the test From information received 
 From previous experience 
  
Awareness of potential harm Radiation exposure 
 Contrast exposure 
  
The role of imaging in clinical care Imaging is beneficial 





Experience of waiting times For the test 
 For results 
  
‘Seeing is believing’ Greater understanding of disease 






3.2.1 Theme 1: Knowledge about the test 
 
     Participants’ knowledge about the test was informed by information they received primarily 
from health professionals, but also from family, friends and the internet. Previous experience 
of imaging tests also informed patients’ understanding. There were varying needs for 
information about the procedures: “How much [information] is too much and how much is not 
enough?” (F73 MRI).  Most were happy with the information they were given: “It all got 
explained to me very well before I went in” (F37 MRI).  
 
     Some participants recalled very little information about the imaging test prior to having it 
done: “None at all, none, none at all, just the letter saying where it is, and that’s it” (F39 MRI). 
Several could not remember whether they were given any information prior to the test 
suggesting that the information they received was not memorable: “They may have done I can’t 
recall” (M66 CT). Some were more interested in getting the test done quickly than being fully 
informed: “We really don’t wanna delve into the ins and outs of it and just do the x-ray and we 
can go home” (M56 CR&CT). Participants who had previous experience of the test in question 
were less concerned about it and required less information, as they knew what to expect: “I 
knew what was gonna happen so, having been there before” (F71 MRI). 
 
  Several participants recommended that further information should be provided about the test 
and potential risks: “Even if the patient has had [one] before, it should be better to make sure 
that the patient is informed of any risks that may be involved” (M55 CT).  
 
     A suggestion for improving patient knowledge was to have information books available in 
the waiting room: “For those people who are concerned about it, they could just have you 
know, something they could read while they wait” (M53 CT). Another was to be shown a 
photograph of the MRI scanner to prepare patients for the confined space: “They should call 
you or text you or send you a letter like highlighting, perhaps with a photograph of the tunnel, 




3.2.2 Theme 2: Awareness of potential harm 
 
     This theme described participants’ awareness of potential harm from the test. Some, but 
not all, were aware of potential harm from radiation or contrast exposure. Those having CR 
and US expressed some confusion regarding radiation exposure during these procedures, 
however a high level of concern was not expressed: “I mean I'm sure it’s there and, well it is 
there, but yeah, I don’t think I've ever had it really explained to me how much is there”  (F54 
CR). “He didn’t leave the room or anything like dentists do when they take an x-ray of your 
teeth, which is a bit upsetting” (F69 US). 
 
     Many were not concerned about radiation during CT scan, but whether this is due to lack 
of knowledge or relaxed participants is uncertain: “No I don’t worry about that.  I think 
there’s a lot of strange fears about radiation and its gone crazy” (M80 CT). There was a lack 
of knowledge about radiation exposure during CT: “I was a little bit surprised to see them 
putting on the lead, you know moving into the other room, you know, indicating that there 
was mild radiation and so on” (M70 CT). MRI participants had no concerns about radiation. 
 
     Most participants  who had MRI scans were aware of potential adverse effects from the 
contrast: “that had been explained well to me here before I went, yip, that that would need to 
be done and that you can get a metallic taste in your mouth from the dye, you get told the side 
effects” (F37 MRI). 
 
3.2.3 Theme 3: The role of imaging in clinical care 
 
     This theme explored the participant perception of the role of imaging tests in arthritis. 
Many participants regarded the imaging tests as nothing out of the ordinary, just part of their 
usual rheumatology clinic care: “I have one done every time, every time I go and visit the 
doctor she does an ultrasound on all fingers and all toes” (F63 US). Participants understood 
the reason for having the test and what information they would expect to receive as a result: 
“And obviously it’s for a reason, to see if she needs to be more aggressive with my treatment, 
in case there is already pitting in the bones and things like that” (F37 MRI).  
 
     They were keen to have imaging tests to provide them with more information about their 
condition: "I was happy because I wanted to know what is happening" (F58 US). Participants 
believed that the benefits of having the test outweighed the potential risks involved and 
preferred knowing more about their disease than less. Some even expressed fear of not having 
the test and the resultant knowledge that comes with it: “You know, ignorance is bliss and it’s 
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also deadly and if you don’t have tests and x-rays and things like that you’d never know 
what’s gonna climb up and push you under the water” (M80 CT). Some felt as if they had no 
choice in the matter and did not challenge their doctor’s decision: “I suppose I just accept 
things that, you know, they say to have an x-ray unless it was absolutely ridiculous I probably 
wouldn’t question it” (F83 CR). 
 
3.2.4 Theme 4: Discomfort 
 
     This theme explored the experience of physical and emotional discomfort during the test.  A 
minority of participants reported emotional discomfort due to negative interactions with staff 
such as feeling rushed during the procedure: “I know they’ve got a schedule that they have to 
keep to but, so they want to get you into the machine as quick as possible…they still ask you all 
the same questions, they’re just a bit more pushy, a bit more rushed” (F37 MRI). Participants 
recommended that radiology staff take their time and try to “make [patients] feel relaxed, talk 
about life…laugh a bit…give them a pleasant environment” (F39 MRI). 
 
     Another type of emotional discomfort experienced was feelings of anxiety or 
claustrophobia. The frequency of this differed significantly between the imaging modalities, 
occurring exclusively with CT and MRI as compared to X-ray and US. One CT participant 
developed claustrophobia: “I'd say 3 on a scale of 1-10 sort of thing” (M73 CT). Several 
participants had feelings of claustrophobia during MRI but despite this they all completed the 
procedure: “I got super surprised when I saw the machine. The actual machine was like a 
closed tunnel, and when I saw that, I panicked and I started like shivering, and I was 
panicking because I have mild claustrophobia and nobody had prepared me for that” (F39 
MRI). Participants who did not suffer from claustrophobia could appreciate the confined 
space of the MRI machine: “I didn’t get freaked out about being enclosed in. But I did go, oh 
this is quite - I can understand why people don’t like this” (F37 MRI). Several coping 
mechanisms were described to reduce anxiety and increase their ability to comply with the 
procedure: “As soon as I felt the table moving in, I shut my eyes; I just thought it was the easy 
way, rather than panic” (F71 MRI). 
 
     Some reported physical discomfort with positioning and difficulty holding still for the time 
required to have the test: “Cos when you have uncomfortable shoulders, things like that, 
laying there for twenty minutes, like superman, is not comfortable…I’m sure people who 
don’t have arthritis, or don’t have muscle and joint pain, could stay in that position for 
longer” (F37 MRI).  
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3.2.5 Theme 5: Experience of waiting 
 
     This theme explored participants’ feelings on waiting for their imaging test and their 
results. Participants who had x-rays and ultrasounds usually had them done on the day of their 
clinic visit, where as those having CTs or MRIs had a longer wait; usually from weeks to 
months. There was a clear preference for the imaging test to be done as quickly as possible: “I 
think any waiting time causes some sort of stress” (M60 MRI). However, despite this, most 
weren’t concerned with waiting times ranging from minutes to weeks: “It would have been 
weeks I think. I was not concerned” (M70 CT). However, some waited significantly longer; 
one participant who waited 3 months for an MRI commented: “it’s quite a long time for those 
who are desperate and seeking an answer, and living with the pain” (F39 MRI).  
 
     Apart from those who had clinic ultrasounds, most interviewees had not yet received their 
test results at the time of the interview. There were mixed reactions over the wait; some were 
frustrated and anxious to find out what the test showed: “I feel that they could have, you 
know, texted me, or emailed me. They have all my information. They know how desperate I 
am for answers” (F39 MRI). Others weren’t sure when they were going to get their results: 
“I’m not expecting to hear anything until I go back which is in three months” (F54 CR) or 
assumed that the lack of contact from their doctor meant everything was okay: “I work on the 
theory that if there’s a problem they’ll get hold of me” (M56 CT). Those who had immediate 
feedback valued it. Immediate feedback primarily occurred for those participants having US: 




3.2.6 Theme 6: ‘Seeing is believing’ 
 
     Participants described viewing their own images positively; this applied predominantly to 
ultrasound scans that were done in rheumatology clinic. The rheumatologists doing the scans 
discussed the images and the findings with the patients. At the time of the interview, most 
participants who had CR, CT or MRI had not seen their images. Participants having US 
described that viewing images provided an explanation for their symptoms, and therefore a 
better understanding of their disease: “I can actually visualise, you know, oh right.  The joints 
are swollen, that’s why it’s, you know, tender and painful” (F55 US). 
 
     Participants also described that viewing their images encouraged a sense of personal 
involvement in their clinical care, so they felt more involved in the consultation and in their 
disease management: “I know what it’s like when you’re having an ultrasound with a baby 
and it’s really important for the, for the mother to look at the screen.  Well you know, that 
one’s a completely different issue, but it’s still as important to be able to see it and feel you’re 
part of it…there’s a sense of being involved” (F63 US). A few CT participants who were 
given print-outs of their images also reported positively: “it’s worthwhile because you can 
relay that information through members of your family, you know, this is how my feet are” 
(M76 CT). 
3.3 Acceptability of the test 
 
     All participants said they would be willing to have the test again in the future, if they 
needed it: “Quite happy if it was going to sort of be of any value to me” (F83 CR). One 
participant did not wish to have another MRI of the wrist, but would be willing to have an 
MRI of a different joint: “Fine, as long as it was a different part of my body…it was just the 
fact that it was a very uncomfortable position to lay in. So if it was an ankle or a knee, I think 





     This study provides valuable insight into the patient experience of undergoing an MSK 
imaging test. Their understanding of the test was informed by the information they received 
and their previous experience of imaging tests. Most were aware of potential harm due to 
intravenous contrast and radiation, however, they perceived imaging as part of standard 
clinical care and believed the benefits of having the test outweighed the potential risks. Some 
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felt anxious about waiting times for the test and for receiving results. Discomfort was 
experienced, both emotional discomfort due to negative experiences of interactions with staff 
and claustrophobia and physical discomfort due to positioning for the test. Visualisation of 
images improves understanding of disease and sense of involvement in their clinical care. 
Participants provided recommendations for improving the overall experience, including the 
need for more information prior to the test and advice for staff to show more empathy and to 




Chapter 4: Methodology for stage two  
 
     This chapter covers the formulation and analysis of the survey questionnaire; giving 
explanations for the rating scale and questions which were chosen. It also discusses the results 
of cognitive testing of the questionnaire and changes that were made to the questionnaire as a 
result of this.  
 
4.1 Development of the questionnaire 
 
     Once the six key themes were identified, the questionnaire for stage two was developed. 
Three members of our research team, including myself, created statements regarding 
musculoskeletal imaging that matched to the themes and subthemes. Each item was followed 
by a Likert rating scale with which respondents expressed the degree of agreement with the 
item statement. The selection of a response format involves consideration of their sensitivity, 
specificity, appropriateness for the subjects and feasibility (Nolan & Mock, 2000). A Likert 
scale was chosen as it is well known and easy to use.  
 
     A scale ranging from 1 to 10 for the questionnaire was chosen.  This gave an even number 
of response options leaving the respondent without a ‘safe’ middle number. Previous research 
has shown that respondents have a greater tendency to choose middle response categories 
when offered them (Si & Cullen, 1998).  
 
     A wide scale range was used as previous research has shown that scales with few response 
categories yield the least reliable scores with significantly reduced reliability, validity, 
variance and discriminating power compared to scales with more response categories (Preston 
& Colman, 2000), although the literature on the optimal number of response categories does 
not provide clear-cut guidance on the precise number of categories.  
 
     When responding to a Likert-like item respondents may specify their level of agreement or 
disagreement with a statement. The range of the scale captures the intensity of the 
participants’ feelings for a given item. Respondents’ perception of shorter scales (up to four 
response categories) is unfavourable as these scales do not allow them to express the intensity 
of their feelings adequately (Preston & Colman, 2000). With a scale of 1 to 10, our 
participants had sufficient range to express the intensity of their feelings. A non-applicable 
option was added to the question items that this applied to. At the end of the questionnaire 
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there was space for participants to write down any recommendations they had to help improve 
the imaging experience. The questionnaire had a Flesch reading level of 6th grade, meaning it 
would be easily readable to an 11 or 12 year old. The pre-cognitive test questionnaire is 
located in appendix B. 
 
     The numbers of the scale do not represent real numbers and could be replaced by letters, 
without affecting the results. Question items were analysed separately rather than as a 
summated score, as there is no underlying quantity that a summated score seeks to represent; 
the questionnaire includes a variety of items covering different topics. 
 
     Each theme and subtheme was mapped to the questionnaire to ensure they were all 
covered. The questionnaire covered the participants’ knowledge about the test, awareness of 
potential harm, the role of imaging in clinical care, discomfort, the experience of waiting and 
‘seeing is believing’. The themes and corresponding questions are shown in table 4.1. Each 
item has been given a short label for easier reference. For the theme ‘knowledge about the 
test’ there was an item about each of the subthemes; information about the test and previous 
experience of the test. For theme two, ‘the awareness of potential harm’, there were items 
about exposure to radiation and contrast and the overall safety of the test.  
 
     There were two items about ‘the role of imaging in clinical care’; one regarding the 
benefits of imaging and one about MSK tests being part of usual clinical care for patients with 
arthritis. There were items about emotional and physical ‘discomfort’ and about staff manner 
during the procedure. Theme 5, ‘the experience of waiting’ was covered by an item about 
waiting for the test and the results. In regards to ‘seeing is believing’ there was an item about 
whether seeing the images helped them to understand their condition better and whether 
looking at the images with their doctor made them feel more involved in their care. At the end 
of the questionnaire there were several blank lines for participants to write any 
recommendations to improve the patient experience.  
 
     In addition there were a few extra items which did not match directly to a theme but which 
were felt to be important. These were regarding the acceptability of the test, staff manner, and 
whether participants were concerned about their results. The final question asked them to rate 





     The layout of a questionnaire needs to be clear and well presented. The question items in 
this questionnaire were numbered and bolded making them easy to follow. The questions 
were grouped in a sequential order ranging from the start of the imaging test process to the 
end. A legible font was used and care was taken not to overfill the pages. 
 
     Validity, the amount of systematic or built-in error in measurement (Norland Tilburg, 
1990) is an important consideration when developing a questionnaire. The research team 
considered the content validity of the questionnaire; that is, whether it actually measured what 
it was intended to measure. Dr Doyle, a co-author and musculoskeletal radiologist provided 
expert advice to help determine this. The questions and range of response options seemed, on 
their face, appropriate for measuring the patient experience of MSK imaging tests. The 
questionnaire covered all aspects of undergoing an MSK imaging test and all questions 
carried equal weight. Other aspects of validity, such as construct validity and criterion validity 
were not assessed since the questionnaire responses were not summated to an overall score. 
 
Reliability refers to the degree to which the results obtained by a measurement or procedure 
can be replicated. Since each item was analysed separately, and were not summated, 
procedures such as Cronbach’s alpha test of internal consistency reliability was not 
appropriate. Test-retest reliability for individual items was not assessed. The feasibility of the 
questionnaire can be assessed by looking at the response rate, the time taken to fill it out and 
data completeness, but this was not formally assessed in this study.  
 
     The aim was to collect questionnaire data from at least 100 people in order to perform 
multivariate analysis, using the rule of thumb of needing at least 10 subjects for each 
independent variable in the model. The survey was posted to consecutive patients undergoing 
MSK imaging until at least 100 responses were received and the time restriction for 
completion of the thesis was met. 
 
4.2  Data analysis of stage two 
 
     Questionnaire data was entered into a Microsoft Access database and then transferred to the 
SPSS (v23, SPSS Inc., Chicago, IL) programme for analysis. Question answers were 
compared across the four different imaging tests. A Bonferroni corrected p value was used to 
minimise type 1 error. This was calculated as critical p value (0.05) / number of comparisons 
(18) = 0.0028. Non-parametric tests were used given the non-normal distribution of item 
responses. Two approaches were taken with this analysis; the first included all imaging tests, 
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which meant that some items within imaging groups came from the same respondent 
(multiple tests per respondent). The second approach required only one imaging procedure 
per subject whereby imaging tests were priority coded as follows MRI > CT > US > CR. For 
the first approach, only descriptive analysis is presented since the imaging grouping variable 
was not independent (responses from the same subject contained in more than one imaging 
group). For the second approach, statistical differences in item responses across the imaging 
tests were examined using the Non-parametric Independent Samples Median Test statistic. 
Spearman rank correlation calculations were used to demonstrate what aspects of the test had 
positive and negative influences on the overall participant experience. Multivariate linear 
regression analysis extended the correlation analysis to determine the independent association 
between different aspects of the test and participants’ overall experience. As the ‘Acceptability 
of the test’ item was highly correlated and conceptually similar to ‘Overall experience’, this item 
was excluded from stepwise linear regression analysis. All regression models included the type 
of imaging test in addition to questionnaire item responses.  
 





Table 4.1. Questionnaire items, corresponding themes and item labels
Item  
 
Item (1 Strongly disagree-10 Strongly agree)  N/A  
option 
Item Label Theme 
1 It was important to have this test to find out about my arthritis  No Importance of test  The role of imaging 
2 Having this test is part of usual clinical care for patients with arthritis  No Part of usual care  The role of imaging 
3 I was concerned about the waiting time for the test  No Waiting for the test  Experience of waiting 
4 I was given enough information about the test  No Information provided Knowledge of test 
5 My experience of having the test before made me more comfortable this time  Yes Previous experience  Knowledge of test 
6 I found this test uncomfortable  No Discomfort during the test Discomfort 
7 I felt anxious during the test  No Anxiety during the test Discomfort 
8 The staff performing the test made the experience better for me No Staff made the experience better  
9 I am concerned about my test results No Concern about result  
10 I don’t mind waiting for my test results Yes Waiting for result Experience of waiting 
11 I found it helpful getting my results at the time of the test  Yes Immediate result  Experience of waiting 
12 Seeing the images helped me understand my condition better  Yes Seeing improves understanding  Seeing is believing 
13 Looking at the images with my doctor made me feel more involved in my care  Yes Seeing improves involvement  Seeing is believing 
14 I would have this test again in the future No Acceptability of the test  
15 I am concerned about exposure to radiation during the test  Yes Radiation concern Awareness of harm 
16 I am concerned about the contrast injection (dye) during the test Yes Contrast concern Awareness of harm 
17 I am concerned about the safety of the test No Safety concern Awareness of harm 




4.3 Results of cognitive testing 
 
     Cognitive testing was performed to ensure that each question was understandable and 
meaningful to the target population (people having MSK imaging for investigation of 
inflammatory arthritis). After obtaining written informed consent ten participants were 
interviewed for cognitive testing of the questionnaire. These participants were recruited from 
Auckland university where they were attending a study visit for gout research. They 
participated in semi-structured recorded interviews that examined the items in the preliminary 
questionnaire, to ensure readability and clarity of the questions. The recorded interviews were 
transcribed verbatim by a professional transcriptionist. The interview questions were revised 
and clarified based on these participants’ comments. Once the questionnaire was finalised it 
was posted out to 514 patients with inflammatory arthritis who met the inclusion criteria, over 
a four month period.  
 
     At the start of the questionnaire there was a tick box section for participant demographic 
information. Under ethnicity there was a tick box entitled ‘other’ for people who did not fit 
into the designated ethnicities. An interviewee asked whether we would want these ‘other’ 
ethnicities to be specified. So a line was added after ‘other’ with the words ‘please specify’. 
 
     ‘Diagnosis’ was changed to ‘type of arthritis’ as several participants wondered whether 
people would understand the word diagnosis. Another comment was that patients may have 
more than one type of arthritis, so ‘tick all that apply’ was added to this section.  
 
     To distinguish between ultrasounds done in clinic and ultrasounds done in the radiology 
department, a separate tick box was created for each. This was done because different answers 
are anticipated for these tests in regards to receiving results and viewing images and therefore 
it is beneficial to have them as separate groups. 
 
     Prior to the Likert items was a sentence that read ‘If you had 2 tests and 1 was an X-ray, 
please answer these next questions for the other test’. This sentence was included because X-
rays are often done in addition to other imaging modalities such as US, CT or MRI. In that 
circumstance we would prefer the participant to fill out the questionnaire for the US, CT or 
MRI as they are less common tests. Several participants found this statement confusing so to 
clarify we added ‘(eg. Ultrasound, CT or MRI). If you only had an X-ray, please answer for 
the X-ray’. The font colour was changed from black to red to draw attention to this statement.  




Table 4.2. Changes made to the questionnaire items following cognitive testing 
Changes Pre-cognitive test  Post-cognitive test 
1 Having this test is part of standard 
clinical care for patients with arthritis 
Having this test is part of usual clinical 
care for patients with arthritis 
   
2 ‘Safety concern’ was before ‘radiation 
concern’ and ‘contrast concern’ 
‘Safety concern’ moved to after 
‘radiation concern’ and ‘contrast 
concern’ 
 
3 I am concerned about the contrast 
injection during the test 
I am concerned about the contrast 
injection (dye) during the test 
   
4 Line spacing for recommendations too 
narrow 
Line spacing for recommendations 
increased 
 
     Change number one involved changing standard clinical care to usual clinical care, as it 
was felt by participants to be easier to understand. Change number two involved changing the 
order of questions based on participant feedback. In the pre-cognitive questionnaire ‘safety 
concern’ came before ‘radiation concern’ and ‘contrast concern’ However the order was 
changed as a participant commented that they would have answered the ‘safety concern’ item 
differently if it came after the ‘radiation and contrast concern’ items, rather than before them. 
Change number three involved the word (dye) being added after contrast injection to ensure 
correct understanding of the word contrast. Another participant observation was that the lines 
on which to write any recommendations were too narrow, so these were spaced out further 
(change number 4). Once all these changes were made we had our final questionnaire, which 
can be found in appendix C. The patient information sheet which accompanied the 




     This chapter describes the formation of the questionnaire from the six key themes 
identified in the qualitative part of the study. It describes the process of cognitive testing and 




Chapter Five: Results of stage two; analysis 
of the questionnaire data 
 
 
This chapter will report the results of stage two, the quantitative component of the study. 
The demographics and disease characteristics of the respondents to the questionnaire will be 
presented. Subsequently the answers to the questions will be analysed and compared across the 
four different MSK tests. Correlation calculations will demonstrate what aspects of the test had 
positive and negative influences on the overall participant experience. Multivariate regression 
analysis will extend the correlation analysis to determine the independent association between 
different aspects of the test and participants’ overall experience. 
 
5.1 Respondent demographics 
 
Questionnaires were posted out to patients with inflammatory arthritis who had had a recent 
MSK imaging test, from August 2016 to November 2016. In total 514 questionnaires were 
posted and there were 108 responses, giving a response rate of 21%. 
 
Table 5.1 outlines the participant demographics. 60% of respondents were female. Median 
age was 61 years with a range from 30 to 89 years. Age was the only characteristic that did 
not have a tick box associated with it, which may explain why only 37 respondents recorded 
their age. The most common ethnicity was NZ/European at 70%. Other ethnicities identified 
were Māori, Asian, Pacific people and Other. Ethnicities listed under ‘Other’ included Russian, 
Latin American, Indian, South African, Sri Lankan and European. Some participants identified 
with more than one ethnicity. In this situation ethnicities were priority coded as follows; Māori >  
Pacific > Asian >  Other  >  NZ/European > Uncertain according to the Statistics NZ guideline 
(Ministry of Health, 2010). The most common type of arthritis was rheumatoid arthritis (57%) 
followed by gout (18%) and psoriatic arthritis (12%). If participants had more than one type of 
arthritis, their arthritis was priority coded as follows; Rheumatoid arthritis > Psoriatic arthritis > 
Gout > Other > Uncertain. Seven percent of participants were uncertain about what type of 
arthritis they had. In total 165 imaging tests were done and sixteen people had more than one 
imaging test. X-ray was the most frequent imaging test, followed by ultrasound. Feet and 
hands were the most common region imaged with 66 tests each.
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Table 5.1. Participant Demographics 
 
Gender (responses= 104) 
Female  62 (60%) 
Male  42 (40%) 
 
Ethnicity (responses= 106) 
NZ/European  74 (70%) 
Other  12 (11%) 
Māori  11 (10%) 
Asian  5  (5%) 
Pacific people  4  (4%) 
 
Type of Arthritis (responses= 101) 
Rheumatoid arthritis  58 (57%) 
Gout  18 (18%) 
Psoriatic arthritis  12 (12%) 
Uncertain  7  (7%) 
Other  6  (6%) 
 
Imaging test (responses= 104) 
Conventional radiography  46 (44%) 
Ultrasound  24 (23%) 
Magnetic resonance imaging  21 (20%) 
Computed tomography  13 (13%) 
Values are the number (%) unless otherwise indicated. 
 
5.2 Data analysis 
 
Questionnaire answers were initially entered into a Microsoft Access database and then 
transferred via MS Excel to the SPSS programme for analysis. Not all respondents answered 
all questions, therefore denominators fluctuate in this section. The answers to each question 
item across all four tests were compared, see Table 5.2. This table shows the participants 
scores (median and range) for each question item and the number of responses to each item 
that were not applicable. As 16 people had multiple tests, participants may appear in more 
than one modality group. Table 5.3 shows identical information but does not contain duplicate 
imaging tests, as tests were priority coded as follows MRI > CT > US > CR. For example a patient 
who had an MRI and an x-ray would be priority coded as being in the MRI group. 
 
There was a wide range of responses for most items. Table 5.3 shows there were no 
significant differences between the four imaging tests for most of the question items. Item 3 
(waiting for the test) and item 8 (staff made the experience better) had p values of less than 0.05. 
However, these items did not reach the Bonferroni corrected p-value (p=0.0028) to indicate 




Table 5.2. Median, range and number not applicable for each question item for all 4 tests (duplicates included) 
 
Questions CR  (n=57) US  (n=39) CT  (n=20) MRI  (n=21) 




Median (range) n(NA) Median (range) n(NA
) 
Importance of the test 10 (4-10) - 10 (7-10) - 10 (3-10) - 10   (5-10) - 
Part of usual care 9 (4-10) - 9 (5-10) - 9 (1-10) - 7.5  (2-10) - 
Waiting for the test 2 (1-9) - 3 (1-10) - 2 (1-10) - 5     (1-10) - 
Information provided 8 (2-10) - 9 (1-10) - 10 (2-10) - 9     (2-10) - 
Previous experience 9 (4-10) 14 8 (1-10) 7 10 (1-10) 5 9     (1-10) 6 
Discomfort during the test 2 (1-10) - 2 (1-8) - 1 (1-10) - 2     (1-9) - 
Anxiety during the test 1 (1-10) - 2 (1-10) - 1 (1-10) - 2     (1-9) - 
Staff made the experience better 9 (2-10) - 9 (6-10) - 10 (5-10) - 10   (6-10) - 
Concern about result 6 (1-10) - 7 (1-10) - 6 (1-10) - 8     (1-10) - 
Waiting for result 6 (1-10) 5 6 (1-10) 8 6 (1-10) 1 5.5  (1-10) 2 
Immediate result 9 (2-10) 32 10 (5-10) 7 10 (1-10) 5 9     (5-10) 9 
Seeing improves understanding 9 (2-10) 33 9 (3-10) 9 10 (2-10) 3 9.5  (3-10) 7 
Seeing improves involvement 9 (1-10) 34 8 (1-10) 9 10 (1-10) 4 8.5  (1-10) 9 
Acceptability of the test 9 (5-10) - 9 (4-10) - 10 (1-10) - 9     (3-10) - 
Radiation concern 3 (1-10) 3 5 (1-10) 6 3.5 (1-10) 0 2     (1-10) 1 
Contrast concern 6 (1-10) 46 5 (1-10) 21 2.5 (1-10) 8 5     (1-10) 6 
Safety concern 2 (1-10) - 2 (1-10) - 1 (1-10) - 2     (1-10) - 
Overall experience 9 (3-10) - 9 (3-10) - 10 (1-10) - 9     (3-10) - 




Table 5.3. Median, range and number not applicable for each question item for all 4 tests (no duplicates) 
 





n(NA) Median (range) n(NA) Median (range) n(NA) p 
Importance of the test 9.5 (4-10) - 9 (7-10) - 10 (3-10) - 10 (5-10) - # 
Part of usual care 9 (4-10) - 9 (6-10) - 8 (1-10) - 7.5 (2-10) - 0.91 
Waiting for the test 1.5 (1-9) - 2 (1-10) - 1 (1-10) - 5 (1-10) - 0.03* 
Information provided 8 (2-10)  9 (1-10) - 10 (2-10) - 9 (2-10) - 0.09 
Previous experience 9 (5-10) 13 8 (1-10) 4 10 (1-10) 4 9 (1-10) 6 0.11 
Discomfort during the  test 1 (1-10) - 1.5 (1-7) - 1 (1-10) - 2 (1-9) - 0.72 
Anxiety during the test 1 (1-10) - 1 (1-10) - 1 (1-10) - 2 (1-9) - 0.28 
Staff made the experience 
better 
9 (2-10) - 8.5 (6-10) - 10 (5-10) - 10 (6-10) - 0.04* 
Concern about result 5.5 (1-10) - 7 (1-10) - 5 (1-10) - 8 (1-10) - 0.08 
Waiting for result 6 (1-10) 5 6 (1-10) 3 8.5 (2-10) 1 5.5 (1-10) 3 0.78 
Immediate result 9.5 (2-10) 30 9.5 (5-10) 4 5 (1-10) 4 9 (5-10) 9 0.10 
Seeing improves understanding 9 (5-10) 33 9 (4-10) 5 10 (2-10) 3 9.5 (3-10) 7 0.47 
Seeing improves involvement 9 (4-10) 32 8 (6-10) 5 10 (2-10) 3 8.5 (1-10) 9 0.44 
Acceptability of the test 9.5 (5-10) - 9 (4-10) - 10 (1-10) - 9 (3-10) - 0.71 
Radiation concern 3 (1-9) 3 5 (1-10) 5 5 (1-10) 0 2 (1-10) 1 0.59 
Contrast concern 6 (4-7) 43 6 (1-9) 17 3 (1-10) 7 5 (1-10) 6 0.76 
Safety concern 2 (1-8) - 2.5 (1-9) - 2.5 (1-9) - 2 (1-10) - 0.87 
Overall experience 9 (5-10) - 9 (6-10) - 9 (6-10) - 9 (3-10) - 0.07 
40 
 







Analysis of the question item scores show that overall participants found the tests 
acceptable and had low levels of concern about the safety of the tests. As we found in the 
interviews, participants believed the tests were important to have to find out more about their 
arthritis and regarded them as part of usual clinical care for people with arthritis. Participants 
valued seeing their images, receiving immediate results and having staff assist during the 
procedure. Discomfort and anxiety during the tests were minor concerns. The majority felt 
well informed about their test and were not concerned about the waiting time prior to the test. 
There was some concern about the results of the test, the waiting time to get results, and 
radiation and contrast exposure. Previous experience of the procedure was beneficial to the 








Table 5.4. Correlation of each questionnaire item with the participants’ overall 
experience (Spearman rank correlation test) 
Question label Correlation 
Coefficient 
P value Number of 
Respondents 
Importance of the test 0.35 <0.001 107 
Part of usual care 0.39 <0.001 102 
Waiting for the test -0.32 0.001 107 
Information provided 0.48 <0.001 107 
Previous experience  0.53 <0.001 80 
Discomfort during the test -0.42 <0.001 107 
Anxiety  during the test -0.35 <0.001 107 
Staff made the experience better 0.56 <0.001 107 
Concern about result -0.18 0.060 107 
Waiting for result 0.33 0.001 95 
Immediate result 0.22 0.097 59 
Seeing improves understanding 0.38 0.003 59 
Seeing improves involvement 0.59 <0.001 58 
Acceptability of the test 0.62 <0.001 105 
Radiation concern -0.36 <0.001 98 
Contrast concern -0.34 0.050 33 
Safety concern -0.32 0.001 105 
 
      
     Table 5.4 shows the bivariate correlations for the ‘overall experience’ item and all other 
questionnaire items. Participants associated seeing their own images with a positive overall 
experience; after ‘Acceptability of the test’, the strongest positive correlation was ‘Seeing the 
images improves involvement in care’. These results show the positive impact that staff had on 







test’ influenced the overall experience in a negative way, as did ‘Radiation concern’ and ‘Safety 
concern’. ‘Discomfort during the test’ had the strongest negative correlation with overall 
experience.  
 
5.2.1 Multivariate analysis 
 
     There was no clear indication about which question items would be most associated with 
the participants’ experience of the imaging test, therefore a stepwise approach was used to 
identify items that were independently associated with overall experience. Stepwise linear 
regression analysis was performed on all question items (excluding the questions with non-
applicable answers and ‘Acceptability of the test’) to determine question items which were 
independently associated with the participants’ overall experience. Four items were found to 
be independently associated with overall experience, see Table 5.5. ‘Staff made the experience 
better’ and ‘Part of usual care’ had positive correlations with overall experience. ‘Discomfort 
during the test’ and ‘Waiting for the test’ had negative correlations with overall experience. 
These four variables accounted for 36% of variance in the regression model. ‘Staff made the 
experience better’ was the strongest single independent predictor of the overall experience 
accounting for 20% of variance  
 
 Table 5.5.  Stepwise linear regression analysis of question items (excluding non-

























































Adjusted R2 = 0.36 
F= 14.9 
p= <0.001 
Items included in this analysis: imaging modality and all questionnaire items that did not 








The assumptions of linear regression were tested by examining the distribution of residuals 
and the assumption of homoscedasticity. Figures 5.1 and 5.2 show that the residuals fit a 


















Figure 5.3. Scatterplot of standardised residuals from the model shown in table 5.5 
 
Figure 5.3 shows that the assumption of homoscedasticity for the model shown in table 5.5 
appears to be met.  
 
     Table 5.6 is identical to table 5.5, apart from the addition of two independent variables; 
‘Seeing improves understanding’ and ‘Seeing improves involvement’. These variables were 
added to determine whether participants seeing their images was an independent predictor of 
overall experience, as previous research has shown that patients who see their images find it 
beneficial in regards to disease understanding and improved patient-doctor interaction 
(Bourke et al., 2017). 
 
     Two variables remained constant as independent predictors of overall experience; ‘Staff 
made the experience better’ and ‘Discomfort during the test.’ ‘Staff made the experience 
better’ remained the strongest single independent predictor accounting for 22% of variance. In 
this model ‘Seeing improves understanding’ was also found to be a positive independent 
predictor of overall experience. These three variables account for 43% of the variance in 








Table 5.6. Stepwise linear regression analysis of question items independently associated 






















































Adjusted R2 =0.43; 
F=14.3; 
p= <0.001 
Items included in this model: all items as per analysis shown in Table 5.5, plus ‘seeing 
improves involvement’ and ‘seeing improves understanding’.  
 
Figures 5.4 and 5.5 demonstrate that residuals from the model shown in table 5.6 form a 


























Figure 5.6 shows that the assumption of homoscedasticity for the model shown in table 5.6 
appears to be met.  
 
5.3 Participants’ recommendations and comments 
 
     Approximately 50% of questionnaire respondents made comments/recommendations about 
their experience. Some were frustrated at the long wait for the result. ‘The x-ray I had was a 
good experience but I would like my results faster - 2 months waiting and I still don't have 
results.’ 
Another participant received their result in a letter from the doctor which they could not 
follow. ‘I couldn't understand the results because I don't know the medical jargon and I found 
this rather frustrating.’ One recommendation was to give patients a copy of their test images 
to take home. ‘I think all patients should be given copies of their imaging on a CD rom for 
future reference.’ 
 
     Participants who saw their images appreciated this. ‘When I do see my images it helps me 
to see my progression and makes me feel involved, as any decisions I may have to make are 
then more informed.’ 
     Discomfort was reported during the test. ‘We must stretch our joints for the x-ray and hold 
certain positions that really are very uncomfortable and painful for us.’ Many participants 
acknowledged the friendly staff that helped them through the procedure.  
‘The staff were absolutely wonderful speaking to me during my MRI which was very 
reassuring.’ 
‘The people administering the test are very kind and made me feel safe.’  
 
     Most participants appeared to be content with the information they received, however 
some wanted more. ‘More information re how imaging works, what they are looking for and 
radiation, so risk can be balanced against need to know proper diagnosis.’  
 
     As in the interviews, participants regarded previous experience as beneficial. ‘Prior 








5.4 Interpretation of results 
 
     Tables 5.2 and 5.3 show that those who had an MRI had a higher median score for 
‘Waiting for the test’ than for the other three imaging tests. This is likely because those that 
had MRIs waited longer for their tests, in comparison to the other modalities. Thompson  
(1995) reported that patient satisfaction is determined by the magnitude and direction of the 
gap between expectations and perceptions of performance; he found that patients were least 
satisfied when waiting times were longer than expected  and vice versa (Thompson & Yarnold, 
1995). Therefore if patients are made aware of the usual waiting time for an imaging test they 
should be less concerned about it. This could also apply to waiting for results.  
     Table 5.3 demonstrates that only 4/28 (17%) of participants who had an US answered not 
applicable to the item ‘Immediate result’, suggesting that 83% of those who had an US 
received results at the time of the test. Of the four imaging modalities, the US group had the 
highest number of participants who received immediate feedback on their test. CT was next 
with 70% of participants receiving immediate feedback, followed by MRI (57%) and CR 
(35%). Several CT participants were recruited from Auckland university where they had a dual 
energy CT scan done as part of a gout study. Study volunteers are routinely shown their images 
by the research team; this likely differs from rheumatology clinical practice and may explain 
the high number of CT participants who had immediate feedback of results. The response to 
this item for MRI may have been affected by multiple imaging modalities, as only nine 
participants had MRI alone. 
 
     Table 5.2 shows that six participants (15%) who had an US answered not applicable to the 
item ‘Radiation concern’, as did 1 MRI participant (5%), suggesting a lack of knowledge on 
the potential risks of tests. On the other hand, no CT participants gave a not applicable answer 
for ‘Radiation concern’ indicating that they knew that a CT scan involves radiation. This is 
consistent with research that has shown that those having CT scans are more likely to know 











This chapter reported the results of stage two, the quantitative component of the study. The 
demographics and disease characteristics of the 108 respondents were presented. The answers 
to each question item were analysed and compared across the four different MSK tests and there 
were no significant differences when the Bonferroni correction was used. 
 
     Most question items correlated with the overall experience item, with the strongest 
correlations for the following items: ‘Acceptability of the test’, ‘Seeing improves 
understanding’, ‘Previous experience’, ‘Staff made the experience better’ and ‘Information 
provided’. 
 
     In stepwise linear regression analysis including imaging modality and all questionnaire 
items (excepting ‘Acceptability of the test’) that did not include a not applicable response, 
four items were independently associated with the overall experience (Table 5,5). ‘Staff made 
the experience better’ was the strongest single independent predictor and accounted for 20% 
of variance in overall satisfaction with the imaging test.  Three further items, ‘Discomfort 
during the test’, ‘Waiting for the test’ and ‘Part of usual care’ were independently associated 
with the overall experience. These four items accounted for 36% of variance in the regression 
model. 
 
     In an analysis of the participants who had viewed their images, ‘Staff made the experience 
better’ was again the strongest single independent predictor of the overall experience and 
accounted for 22% of variance (Table 5.6). Two further items, ‘Discomfort during the test’ 
and ‘Seeing improves understanding’ were also independently associated with the overall 
experience.  These three items accounted for 43% of variance in the regression model. The 
regression residuals fit within a normal distribution curve and the assumption of 











Chapter Six: Discussion 
 
6.1 Limitations and Strengths 
 
     This study has potential limitations. An unavoidable limitation in the qualitative 
component of the study is the researcher’s presence during data gathering, which may affect 
the subjects’ responses (Anderson, 2010). Stage one and two participants responded to an 
invitation to participate in the study, and it is possible that the experience of those who did not 
respond to the invitation may have differed from those who participated in the study (non-
response bias). The key limitation for stage two was the low response rate (21%). Those with 
very negative or positive experiences may have been more likely to respond. Nevertheless, the 
low response rate should not substantially influence the analysis of factors associated with the 
patient experience. A previous study researched mail survey response rates published in seven 
general health education journals and found that a noteworthy percentage of studies had a 
response rate of less than 50% (Price et al., 2004). 
 
     Both stages of the study were retrospective, so despite the short time period between the 
test and interview or questionnaire, participants may have forgotten some aspects of their 
experience. Stage two involved patients attending two public healthcare rheumatology units in 
New Zealand; the experience of waiting times for tests and results may differ in different 
healthcare systems. Many study participants were not concerned about radiation exposure; the 
reason for this is unclear and could have been explored further during the qualitative 
interviews. 
 
     Only 37/108 (34%) of questionnaire respondents filled out their age. Unlike the other 
demographic characteristics, age did not have an associated tick box, which may explain its 
low response rate. As it was an anonymous postal questionnaire there was no ability to be 
able to explain questions that participants might misinterpret, hence prior cognitive testing of 
the questionnaire was undertaken to try to reduce potential differences in understanding and 
misinterpretation of the questions. As this study was conducted in a single centre, the findings 








      The ability to capture and portray the participant perspective of MSK imaging was one of 
the study’s strengths and also central to promoting authenticity and credibility; both important 
criteria for enhancing rigour (Milne & Oberle, 2005). Recording and transcribing the 
interviews verbatim ensured accuracy of the data as well as scientific and ethical integrity. 
Being a mixed methods study provided a more complete and comprehensive understanding of 
the patient experience of MSK imaging, than either approach would have alone and led to a 
questionnaire with greater construct validity. 
 
6.2 How this fits with what we know and implications of these 
results in clinical practice 
 
     This study has shown that patients undergoing musculoskeletal imaging tests for 
investigation of inflammatory arthritis have a wide range of experiences. Patients with 
arthritis believe MSK imaging tests are beneficial and part of standard clinical care. Despite 
some anxiety, all participants in our study completed their imaging procedures. The 
motivation for doing so may be their belief that the test result is important to their disease 
management. In general, participants were not concerned about waiting several weeks for an 
imaging test, but did appreciate immediate feedback of results. Processes to provide more 
rapid feedback of imaging results may improve the patient experience of the test, and lead to a 
greater sense of involvement in their clinical care.  
 
     Some study participants had a lack of understanding about the potential risks of tests such 
as radiation exposure. Several previous studies have reported a lack of patient understanding 
of diagnostic tests (Quirk et al., 1989; Repplinger et al., 2016). Other studies have highlighted 
initiatives by patients to learn more about their examination from alternate sources, such as 
the internet or from family or friends (Rosenkrantz & Flagg, 2015), indicating their desire to 
become more educated about their care. This study has raised the issue of patients receiving 
adequate and tailored information about imaging tests. 
 
     In those patients who viewed their images, ‘seeing the images helped me understand my 







prior qualitative studies of patients undergoing imaging procedures, which report that viewing 
images can improve patient understanding of their disease process, impact on patient health 
behaviour intentions, and positively influence the nature of the interactions between the 
patient and clinician (Bourke et al., 2017; Carlin et al., 2014; Devcich et al., 2014). In the area 
of musculoskeletal imaging, a previous questionnaire study also reported that viewing images 
in real-time during ultrasound-guided joint injection improved patient understanding of the 
procedure and reduced anxiety about the test in the majority of patients (Sahbudin et al., 
2016). Collectively, these data strongly support the process of viewing images with the 
patient. One way to improve the patient experience of undergoing MSK imaging is to show 
patients their images more frequently. Providing printouts or copies of relevant images may 
further enhance patient understanding of disease processes and management. 
 
     This study showed that some participants were frustrated by the wait for their results 
and/or their test. Chesson (2002) discovered that the majority of patients who had an 
outpatient US, CT or MRI expected to receive their results within two weeks of the test 
(Chesson et al., 2002). This unrealistic expectation likely contributes to patients’ 
dissatisfaction with waiting times. This discrepancy between expectation and reality could be 
avoided if referring clinicians state clearly when patients are likely to have their test and 
receive their result. 
 
     Interaction with staff during the test was the strongest independent factor associated with a 
positive overall experience in both regression models. These findings are consistent with a  
previous MRI study that emphasized the value of positive interactions with radiology staff; 
with reassurance, prior explanation of the procedure, communication throughout and staff 
manner identified as important (MacKenzie et al., 1995). People often need support during 
scanning from staff members, who have a large impact on the scan experience, either in a 
positive or negative way (Munn & Jordan, 2011). 
 
     The median disease duration for participants in stage one was 9 years. It is possible that 
patients who are newly diagnosed with inflammatory arthritis have different experiences of 
MSK imaging tests to those with long-standing disease. This is something that could be 








     Physical and emotional discomfort were experienced by participants during the imaging 
procedures. Emotional discomfort caused by claustrophobia is common during MRI (Dewey 
et al., 2007; MacKenzie et al., 1995; Melendez & McCrank, 1993). Newer MRI machines 
have lower rates of claustrophobia, due to a more patient friendly design (Dewey et al., 2007), 
however they have not removed it completely. A recent meta-analysis of people undergoing 
MRI, reported  that approximately 1 out of 100 people scanned experienced a claustrophobic 
reaction resulting in premature termination of the procedure (Munn et al., 2015). Patients with 
more information about MRIs have been shown to be less anxious (Grey et al., 2000). Based 
on our study observations we recommend patients are provided with sufficient information 
about claustrophobia-inducing features of MSK tests such as confined space, noise and heat. 
A photograph of the CT or MRI machine may be beneficial when explaining this experience 
in patient educational material. 
 
     In both regression models, ‘Discomfort during the test’ was a strong independent predictor 
of the overall patient experience. Discomfort during peripheral joint imaging may be a 
particular issue for patients with inflammatory arthritis due to joint tenderness, pain on 
movement during positioning, and stiffness after the prolonged inactivity that is required for 
some scans. Some degree of joint pressure or manipulation may be required for acquisition of 
good quality images. However, careful consideration of pain relief prior to scanning and 
attention to reduce patient discomfort during scanning may be of benefit in improving the 
patient experience of these tests. There is no previous literature on discomfort during MSK 
imaging; however we can extrapolate from other studies. Prior information on discomfort has 
been shown to help women perceive less discomfort during mammography (Keefe et al., 
1994). Hence, if patients with arthritis receive education about discomfort associated with 











     The aims of this study which were to understand the patient experience of undergoing 
MSK imaging tests and to identify factors that contribute most to the patient experience were 
met. This study has identified factors before, during and after an MSK imaging test that 
contribute to the overall patient experience. Our hypothesis that patients with inflammatory 
arthritis would have specific preferences for MSK imaging tests, was supported by the data 
analysis. Participants in this study preferred to receive more information about tests, to have 
positive interactions with staff and to be shown their images.  
 
     Many of the factors associated with the experience of MSK imaging in our study are 
modifiable, and focusing on these factors may improve the patient experience. Based on the 
study observations, the investigators recommend that patients having MSK imaging tests for 
investigation of inflammatory arthritis are given sufficient information about the test 
including the approximate waiting time for the test and results, the possibility of experiencing 
discomfort during the test, and the potential risks of the test. Careful attention to patient 
comfort by staff during positioning and scanning may be of particular importance for patients 
with joint pain due to inflammatory arthritis. The patient experience could be further 
improved by providing rapid feedback of results and showing the patients their images, to 
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Appendix A: The interview schedule 
 
Interview Guide Questions for ‘The patient experience of 
musculoskeletal imaging’ study: part 1 
Introductions 
Answer any questions participants have 
Explain the purpose of the interviews  
Take consent 
Explain the recording device 
 
First I have a few questions about you and your arthritis: 
Questionnaire 
1. Date of interview 
2. What is your age?  
3. What is your gender? 
4. Please indicate the ethnic group(s) you belong to 
5. What type of arthritis do you have?  
6. How long have you had it for? 
7. What was the date of the test?  
8. What joint did you have imaged? 
9. What test did you have done? 









Can you tell me about your arthritis? How does it impact on your life? 
 
Section 1: Pre-test 
• Please can you start by telling me about why the test was arranged? 
• How did you feel when you were told you needed to have an imaging test? 
• Were the advantages and disadvantages of different tests discussed with you? 
• How long did you wait before the test?  
• How did you feel about the waiting time? 
• How did you feel about the test while you were waiting?  
• What information did you receive about the test before you had it? 
• How did you get this information (prompts: Internet? Other patients? Rheumatologist? 
Radiology department?) 
• How did the information make you feel?  
• Do you have any suggestions for improving the information provided? 
 
Section 2: Having the test 
• What was it like, just getting to the place where the test was done? 
• Please can you tell me a little bit about what happened when you had the test? (break 
down into sequential sections: getting prepared including changing/exposure, positioning, 
during scan, after scan) 
• How did you feel when you were having the test? (prompts based on previous research – 
any feelings of claustrophobia/feeling trapped; anxious; lack of control ; discomfort 
related to positioning; ?pain – if any of these feelings reported – how did you manage e.g. 
your feelings of anxiety?) 
• Did you feel well supported by the staff performing the test? Do you feel they 
communicated well with you? Is there anything you think the staff performing the test 
could have done to make the experience better for you? 
 
Section 3: Post-test 
• Who gave you the results of your test? When was this? What did they tell you? 
• What do you feel about how the test results were explained? 
• What you do feel about the test results? 
 
Section 4: Overall reflections about the test 
• What did you like about the test? 
• What didn’t you like about the test? 
• Do you have any concerns about the safety of the test? (prompts: radiation, iv contrast) 
• If you had to have this imaging test again, how would you feel? 
• If your family or friends needed to have this imaging test, what advice would you give 
them?  
• What advice would you give health professionals to help them improve your experience of 
the test? 












Locality:  University of Auckland Ethics committee ref.: 15/CEN/188 
Lead investigator: Dr Sandra Bourke Phone: 02102225304 
 
Please start by answering the following questions about yourself 
Age:  Gender:   Female Ethnicity:  NZ/European  Diagnosis:  Rheumatoid arthritis 
   Male   Māori   Psoriatic arthritis 
     Pacific People   Gout 
     Asian   Other 
     Other   Uncertain 
 
Joint that was imaged:  Foot *Imaging test that you had:  X-ray 
    Ankle    Ultrasound 
    Knee    CT 
    Hand      MRI 
    Wrist  
    Elbow 
 
*If you had 2 tests and 1 was an X-ray, please answer these next questions for the other test 
Please think about your recent imaging test (X-ray, Ultrasound, CT or MRI) and circle 
a number between one and ten for the following statements.  
 
1. It was important to have the test to find out about my arthritis 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
 
2. Having this test is part of standard clinical care for patients with arthritis 
 
Strongly Disagree                                                                                                             Strongly Agree 








3. I was concerned about the waiting time for the test 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
4. I was given enough information about the test 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
5. My experience of having this test before made me feel more comfortable this time 
 
Strongly Disagree                                                                                                            Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
6. I found the test uncomfortable 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
7. I felt anxious during the test 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
8. The staff performing the test made the experience better for me 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
9. I am concerned about my test results  
 
Strongly Disagree                                                                                                             Strongly Agree 








10.  I don’t mind waiting for my test results 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
11.  I found it helpful getting my results at the time of the test 
 
Strongly Disagree                                                                                                            Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
12.  Seeing the images helped me understand my condition better 
 
Strongly Disagree                                                                                                            Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
13.  Looking at the images with my doctor made me feel more involved in my care 
 
Strongly Disagree                                                                                                            Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
14. I would have this test again in the future 
 
Strongly Disagree                                                                                                            Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
15. I am concerned about the safety of the test 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10 
 
16. I am concerned about exposure to radiation during the test 
 
Strongly Disagree                                                                                                             Strongly Agree 








17. I am concerned about the contrast injection during the test 
 
Strongly Disagree                                                                                                             Strongly Agree 
             1             2             3             4             5             6             7             8             9             10            Not Applicable 
 
18. My overall experience of the test was 
 
Very unpleasant                                                                                                                       Excellent 
             1             2             3             4             5             6             7             8             9             10 
 





















Please start by answering the following questions about yourself 
  
Age:  Gender:  Female Ethnicity:    NZ/European  Type of arthritis:    Rheumatoid arthritis 
                        Male                      Māori Tick all that apply    Psoriatic arthritis 
                        Pacific People       Gout 
                        Asian       Other 
                        Other _________                                  Uncertain 
        (please specify) 
 
Joint that was imaged:  Foot  * Imaging test that you had       X-ray 
Tick all that apply  Ankle   Tick all that apply                       Ultrasound (in clinic) 
                                           Knee                                                                                                             Ultrasound (in radiology dept) 
   Hand            CT 
   Wrist           MRI 
   Elbow 
    
 
 
* If you had two tests and one was an X-ray, please answer these next questions for the other 
test (eg. Ultrasound, CT or MRI). If you only had an X-ray, please answer for the X-ray. 
 
 
Please think about your recent imaging test (X-ray, Ultrasound, CT or MRI) and circle a 




1. It was important to have the test to find out about my arthritis 
 
Strongly Disagree                                                                                                                Strongly Agree 




2. Having this test is part of usual clinical care for patients with arthritis 
 
Strongly Disagree                                                                                                                Strongly Agree 





Questionnaire      
 
  
Locality:  University of Auckland Ethics committee ref.: 15/CEN/188 







3. I was concerned about the waiting time for the test  
 
Strongly Disagree                                                                                                                Strongly Agree 




4. I was given enough information about the test 
 
Strongly Disagree                                                                                                                Strongly Agree 




5. My experience of having this test before made me feel more comfortable this time 
 
Strongly Disagree                                                                                                                Strongly Agree 




6. I found the test uncomfortable 
 
Strongly Disagree                                                                                                                Strongly Agree 




7. I felt anxious during the test 
 
Strongly Disagree                                                                                                                Strongly Agree 




8. The staff performing the test made the experience better for me 
 
Strongly Disagree                                                                                                                Strongly Agree 




9. I am concerned about my test results  
 
Strongly Disagree                                                                                                                Strongly Agree 




10.  I don’t mind waiting for my test results 
 
Strongly Disagree                                                                                                                Strongly Agree 




11.  I found it helpful getting my results at the time of the test 
 
Strongly Disagree                                                                                                                Strongly Agree 












Strongly Disagree                                                                                                                Strongly Agree 




13. Looking at the images with my doctor made me feel more involved in my care 
 
Strongly Disagree                                                                                                                Strongly Agree 




14. I would have this test again in the future  
 
Strongly Disagree                                                                                                                Strongly Agree 




15. I am concerned about exposure to radiation during the test 
 
Strongly Disagree                                                                                                                Strongly Agree 




16. I am concerned about the contrast injection (dye) during the test 
 
Strongly Disagree                                                                                                                Strongly Agree 




17. I am concerned about the safety of the test  
 
Strongly Disagree                                                                                                                Strongly Agree 




18. My overall experience of the test was 
 
Very unpleasant                                                                                                                       Excellent 


















Appendix D: Participant 





Study title:  
 
 
The patient experience of musculoskeletal imaging: interviews 
Locality:  University of Auckland Ethics committee ref.: 15/CEN/188 
Lead investigator: Dr Sandra Bourke Contact phone number:  02102225304 
 
You are invited to take part in a study on the patient experience of different imaging tests for 
arthritis.  Whether or not you take part is your choice.  If you don’t want to take part, you don’t 
have to give a reason, and it won’t affect the care you receive.  If you want to take part now, 
but change your mind later, you can pull out of the study at any time.   
 
This Participant Information Sheet will help you decide if you’d like to take part.  It sets out why 
we are doing the study, what your participation would involve, what the benefits and risks to 
you might be, and what would happen after the study ends.  We will go through this information 
with you and answer any questions you may have.  You do not have to decide today whether 
or not you will participate in this study. Before you decide you may want to talk about the study 
with other people, such as family, whānau, friends, or healthcare providers.  Feel free to do 
this. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last 
page of this document.  You will be given a copy of both the Participant Information Sheet and 
the Consent Form to keep. 
 
This document is five pages long, including the Consent Form.  Please make sure you have 
read and understood all the pages. 
 
What is the purpose of the study? 
The purpose of this study is to find out the experience of patients with arthritis who have had 








The information from this study will help doctors decide which imaging test to order for people 
with arthritis. 
 
What will my participation in the study involve? 
You have been chosen to participate as you have had an imaging test of a joint (X-ray, 
ultrasound, CT or MRI) done within the last 6 weeks.  
 
We would like to interview you to find out your experience of that imaging test. This will be a 
one off interview and will take about one hour.  The interview will be taped.  The tapes will be 
held in a secure storage place at Auckland University for 10 years and then destroyed.  
 
What are the possible benefits and risks of this study? 
This study will give us information on what patients like or dislike about different imaging tests.   
 
Doctors can use this information to make sure they order tests that patients are happy with.  
 
We will keep your medical information private and you will not be identified in any study reports. 
 
Who pays for the study? 
It will not cost you anything to do this study.  We will cover your travel expenses and give you 
a $20 gift voucher in appreciation of your participation. 
 
This study has been funded by a grant from Arthritis New Zealand. 
 
What if something goes wrong? 
If you were injured in this study, which is unlikely, you would be eligible to apply for 
compensation from ACC just as you would be if you were injured in an accident at work or at 
home. This does not mean that your claim will automatically be accepted. You will have to 
lodge a claim with ACC, which may take some time to assess. If your claim is accepted, you 
will receive funding to assist in your recovery. 
 
If you have private health or life insurance, you may wish to check with your insurer that taking 








What are my rights? 
Participation in this study is voluntary (your choice). You are free to decline to participate or 
withdraw from the research at any time without any disadvantage to you.  
 
You have the right to access information about you collected as part of the study. 
 
What happens after the study or if I change my mind? 
All data will be kept private and stored securely for 10 years before being destroyed. The study 
will take over a year to complete.  We will send you a letter with results of the study at the end 
of this time.  
 
We plan to publish results from this study in scientific journals so that the information is freely 
available to other doctors, scientists and the public. Patients will not be identified in any 
report or publication and all information about your identity will be kept strictly confidential. 
 
Who do I contact for more information or if I have concerns? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
 Dr Sandra Bourke 
 Telephone number: 02102225304 
 Email: s.bourke@auckland.ac.nz 
 
Or:  Professor Nicola Dalbeth 
 Telephone number: 9232568 
 Email: n.dalbeth@auckland.ac.nz  
 
If you require Māori cultural support, talk to your whānau in the first instance. 
Alternatively you may contact the administrator at He Kamaka Waiora (Māori Health 
Team, Auckland District Health Board) by telephoning 09 486 8324 ext 2324. 
 








Phone: 0800 4 ETHICS 
 Email:  hdecs@moh.govt.nz 
 
Although the health and disability ethics committee has approved the information 
provided in this informed consent form and has granted approval for the investigator 
to conduct the study, this does not mean the ethics committee has approved your 
participation in the study.  You must evaluate the information in this informed consent 















I have read, or have had read to me in my first language, and I 
understand the Participant Information Sheet.   
  
I have been given sufficient time to consider whether or not to 
participate in this study. 
  
I have had the opportunity to use a legal representative, whanau/ 
family support or a friend to help me ask questions and understand 
the study. 
  
I am satisfied with the answers I have been given regarding the 
study and I have a copy of this consent form and information sheet. 
  
I understand that taking part in this study is voluntary (my choice) 
and that I may withdraw from the study at any time without this 
affecting my medical care. 
  
I consent to the research staff collecting and processing my 
information, including information about my health. 
  
If I decide to withdraw from the study, I agree that the information 
collected about me up to the point when I withdraw may continue to 
be processed. 
Yes  No  
I agree to an approved auditor appointed by the New Zealand 
Health and Disability Ethic Committees, or any relevant regulatory 
authority or their approved representative reviewing my relevant 
medical records for the sole purpose of checking the accuracy of 
the information recorded for the study. 
  
I understand that my participation in this study is confidential and 
that no material, which could identify me personally, will be used in 
any reports on this study. 
  









I know who to contact if I have any questions about the study in 
general. 
  
I understand my responsibilities as a study participant.   
 
Declaration by participant: 







Declaration by member of research team: 
 
I have given a verbal explanation of the research project to the participant, and have 
answered the participant’s questions about it.   
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The patient experience of musculoskeletal imaging: questionnaire 
Locality:  University of Auckland Ethics committee ref.: 15/CEN/188 
Lead investigator: Dr Sandra Bourke Contact phone number:  02102225304 
 
 
You are invited to take part in a study on the patient experience of different imaging tests for 
arthritis.  Whether or not you take part is your choice.  If you don’t want to take part, you don’t 
have to give a reason, and it won’t affect the care you receive.   
 
This Participant Information Sheet will help you decide if you’d like to take part.  It sets out why 
we are doing the study, what your participation would involve, what the benefits and risks to 
you might be, and what would happen after the study ends.  You do not have to decide today 
whether or not you will participate in this study. Before you decide you may want to talk about 
the study with other people, such as family, whānau, friends, or healthcare providers.  Feel 
free to do this. 
 
If you agree to take part in this study, you will be asked to complete an anonymous 
questionnaire about your experiences of your imaging test.  You can keep a copy of this 
Participant Information Sheet. 
 
This document is three pages long.  Please make sure you have read and understood all the 
pages. 
 
What is the purpose of the study? 
The purpose of this study is to find out the experience of patients with arthritis who have had 
imaging tests including X-rays, ultrasound, CT scans and MRI scans.  
 








What will my participation in the study involve? 
You have been chosen to participate as you have had an imaging test of a joint (X-ray, 
ultrasound, CT or MRI) done within the last 6 weeks. 
 
We would like you to fill out a questionnaire on how you found that imaging test.  The 
questionnaire should not take longer than 10 minutes to complete.  We ask you to complete 
the questionnaire after your test and post it back to us in a self-addressed envelope.  
 
What are the possible benefits and risks of this study? 
This study will give us information on what patients like or dislike about different imaging tests.   
 
Doctors can use this information to make sure they order tests that patients are happy with.  
 
We will keep your medical information private and you will not be identified in any study reports. 
 
Who pays for the study? 
It will not cost you anything to do this study.  
 
This study has been funded by a grant from Arthritis New Zealand.  
 
What if something goes wrong? 
If you were injured in this study, which is unlikely, you would be eligible to apply for 
compensation from ACC just as you would be if you were injured in an accident at work or at 
home. This does not mean that your claim will automatically be accepted. You will have to 
lodge a claim with ACC, which may take some time to assess. If your claim is accepted, you 
will receive funding to assist in your recovery. 
 
If you have private health or life insurance, you may wish to check with your insurer that taking 
part in this study won’t affect your cover. 
What are my rights? 
Participation in this study is voluntary (your choice). You are free to decline to participate or 








What happens after the study or if I change my mind? 
All data will be anonymous and stored securely at Auckland University for 10 years before 
being destroyed. 
 
We plan to publish results from this study in scientific journals so that the information is freely 
available to other doctors, scientists and the public. Patients will not be identified in any 
report or publication and all information about your identity will be kept strictly confidential. 
  
Who do I contact for more information or if I have concerns? 
If you have any questions, concerns or complaints about the study at any stage, you can 
contact:  
 Dr Sandra Bourke 
 Telephone number: 02102225304 
 Email: s.bourke@auckland.ac.nz 
 
Or:  Professor Nicola Dalbeth 
 Telephone number: 9232568 
 Email: n.dalbeth@auckland.ac.nz  
 
If you require Māori cultural support, talk to your whānau in the first instance. 
Alternatively you may contact the administrator at He Kamaka Waiora (Māori Health 
Team, Auckland District Health Board) by telephoning 09 486 8324 ext 2324. 
 
You can also contact the health and disability ethics committee (HDEC) that approved this 
study on: 
Phone: 0800 4 ETHICS 
 Email:  hdecs@moh.govt.nz 
Although the health and disability ethics committee has approved the information 
provided in this informed consent form and has granted approval for the investigator 
to conduct the study, this does not mean the ethics committee has approved your 
participation in the study.  You must evaluate the information in this informed consent 
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